Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Articles

Page Path
HOME > Cancer Res Treat > Volume 44(1); 2012 > Article
Special Article Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2009
Kyu-Won Jung, MS1, Sohee Park, PhD1, Hyun-Joo Kong, MS1, Young-Joo Won, PhD1, Joo Young Lee, MD1, Hong Gwan Seo, MD, PhD2, Jin-Soo Lee, MD, PhD1
Cancer Research and Treatment : Official Journal of Korean Cancer Association 2012;44(1):11-24.
DOI: https://doi.org/10.4143/crt.2012.44.1.11
Published online: March 31, 2012

1The Korea Central Cancer Registry, Division of Cancer Registration and Surveillance, National Cancer Center, Goyang, Korea.

2National Cancer Control Institute, National Cancer Center, Goyang, Korea.

Correspondence: Sohee Park, PhD. The Korea Central Cancer Registry, Division of Cancer Registration and Surveillance, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 410-769, Korea.
Tel: 82-31-920-2015, Fax: 82-31-920-2179, shpark@ncc.re.kr
• Received: March 2, 2012   • Accepted: March 5, 2012

Copyright © 2012 by the Korean Cancer Association

This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 21,122 Views
  • 124 Download
  • 230 Crossref
  • 233 Scopus
prev next
  • Purpose
    This study overviews nationwide cancer statistics, including incidence, mortality, survival, and prevalence, and their trends in Korea based on 2009 cancer incidence data.
  • Materials and Methods
    Incidence data from 1993-2009 were obtained from the Korea National Cancer Incidence Database, and vital status was followed through 31 December 2010. Mortality data from 1983-2009 were obtained from Statistics Korea. Crude rates and age-standardized rates for incidence, mortality, and prevalence; and relative survival were calculated.
  • Results
    In total, 192,561 cancer cases and 69,780 cancer deaths were observed during 2009, and 808,503 10-year cancer prevalent cases occurred in Korea as of 1 January 2010. The incidence rate for all cancers combined showed an annual increase of 3.3% from 1999 to 2009.
  • Conclusion
    Stomach, liver and cervical cancers have been decreasing and thyroid, breast and colorectal cancers have been increasing at large. In particular, in 2009, colorectal cancer became the third most common cancer in females and for the first time ranked higher than stomach cancer, which had been the long-standing common cancer in Korea. While overall cancer incidence has been rapidly increasing in Korea, age-standardized cancer mortality rates have been declining since 2002, and cancer survival has been improving.
Cancer has been the leading cause of death in Korea since 1983 [1] and has drawn much public health attention. More than 180,000 new cancer cases are diagnosed annually in Korea, and one of four deaths results from cancer [2,3]. This study provides an overview of the nationwide cancer statistics, including the incidence, mortality, prevalence, survival rates, and their trends in Korea.
1. Data sources
The Korean Ministry of Health and Welfare, initiated a nationwide hospital-based cancer registry called the Korea Central Cancer Registry (KCCR) as early as 1980. The registry collected 80-90% of cancer cases annually from more than 180 training hospitals throughout the country. In 1999, the KCCR expanded cancer registration to cover the entire population under the Population-Based Regional Cancer Registry program. Details of the history, objectives, and activities of the KCCR have been documented [4]. Incidence data from 1999 to 2009 were obtained from the Korea National Cancer Incidence Database (KNCI DB). The completeness of incidence data for 2009 was 97.2%, as determined by the Ajiki method [5].
Cancer cases were classified according to the International Classification of Diseases for Oncology, 3rd edition [6] and converted according to the International Classification of Diseases, 10th edition (ICD-10) [7]. The survival analysis used 1,804,388 cancer cases first diagnosed during 1993-2009 from the KNCI DB, and followed vital status through 31 December 2010.
Mortality data from 1983-2009 were obtained from Statistics Korea [1]. The cause of death was coded and classified according to the ICD-10. Population data were also obtained from Statistics Korea using the resident registration population on July 1 of specified years.
Crude rates (CRs) and age-specific rates of cancer incidence and mortality were calculated. Age-standardized rates (ASRs) were determined using the World Health Organization world standard population [8]. The cumulative risks of cancer incidence, which represent the probability of developing cancer during a lifetime, were also calculated. Changes in the annual ASRs of cancer incidence were examined by calculating the annual percentage change over a time period as (exp(b)-1)×100, where b is the slope of the regression of log ASR for a given calendar year [9].
Prevalence was also estimated to assess the level of cancer burden, which represents new and pre-existing cancer patients diagnosed during a given period of time who were still alive on an index date. Using the cancer incidence database from 2000-2009, we calculated the limited-duration prevalence, such as the 1-, 5-, and 10-year prevalence. For example, the 10-year prevalence was calculated from the number of people alive on 1 January 2010 who had been diagnosed with cancer within the previous 10 years. We applied the counting method using SEER*Stat software [10] to calculate the number of cases while adjusting for patients lost to follow-up [9].
The survival duration of each case was determined as the interval between the date of initial diagnosis and the date of death, date of loss to follow-up, or closing date for follow-up. Observed survival rates were calculated using the life table method and relative survival rates were examined with the Ederer II method [11] using an algorithm written in SAS by Dickman [12], with some minor modifications.
1. Incidence
Table 1 presents the overall number of cancer incident cases, deaths, and prevalent cases during 2009 in Korea by sex and cancer site. In 2009, 192,561 cancer incident cases and 69,780 deaths were observed in Korea. As of 1 January 2010, 808,503 10-year cancer prevalent cases were observed in Korea. The cumulative risk for developing cancer during a lifetime was 37.9% for men and 32.7% for women in 2009.
Table 2 shows the cancer incidence rates by sex in 2009. The CRs of all sites combined in 2009 were 398.9 and 376.7 per 100,000 in males and females, respectively. The ASRs of all sites combined were 325.5 and 259.3 per 100,000 in males and females, respectively. In males, the five leading primary cancer sites were the stomach (CR, 80.2; ASR, 64.5), colon and rectum (CR, 60.6; ASR, 49.0), lung (CR, 56.4; ASR, 46.8), liver (CR, 47.9; ASR, 37.7), and prostate (CR, 29.6; ASR, 24.8), accounting for 68.8% of all newly diagnosed cancers in 2009. In females, the most common cancer sites were the thyroid (CR, 108.2; ASR, 79.6), breast (CR, 54.1; ASR, 38.3), colon and rectum (CR, 40.0; ASR, 25.9), stomach (CR, 39.4; ASR, 25.5), lung (CR, 22.8; ASR, 13.9), and liver (CR, 16.2; ASR, 10.4), accounting for 74.6% of all newly diagnosed cancers. Thyroid cancer alone accounted for 28.7% (n=26,815) of incident cases in females in 2009.
2. Mortality
In total, 69,780 cancer deaths were reported in Korea during 2009, accounting for 28.3% of all deaths (Table 3). In 2009, the CRs of all sites combined were 176.3 and 104.7 per 100,000 for males and females, respectively. The ASRs of all sites combined were 146.7 and 62.9 per 100,000 for males and females, respectively. Cancers of the lung, liver, stomach, and colon and rectum were the most common fatal cancers, accounting for about 62.1% of all cancer deaths in 2009 (Table 4).
In males, the five leading fatal primary cancer sites in 2009 were the lung (CR, 43.8; ASR, 36.6), liver (CR, 33.9; ASR, 27.1), stomach (CR, 26.9; ASR, 22.3), colon and rectum (CR, 15.8; ASR, 13.2), and pancreas (CR, 9.0; ASR, 7.4). In females, lung cancer mortality (CR, 16.3; ASR, 9.2) increased gradually and was the most fatal cancer site in 2009, followed by the stomach (CR, 13.9; ASR, 8.1), colon and rectum (CR, 12.6; ASR, 7.3), liver (CR, 11.4; ASR, 6.9), and breast (CR, 7.6; ASR, 5.2).
3. Trends in cancer incidence
Tables 5-7 present the cancer incidence rates during 1999-2009 in Korea for all sites combined and for selected cancer sites. The incidence rate for all sites combined increased by 3.3% annually (1.6% in males, 5.3% in females) from 1999 to 2009. The rapid increase in cancer incidence is also illustrated in Fig. 1.
As shown in Fig. 2, the incidence rates have continued to increase for colorectal and thyroid cancers in both sexes, along with breast cancer in females and prostate cancer in males. In contrast, the incidences of liver cancer in both sexes and cervical cancer in females have decreased. Stomach cancer incidence rates remained the same in males and females. One notable aspect was the sharp increase (25.1% annually) in the incidence of thyroid cancer in females. Improvements in the sensitivity of diagnostic techniques for thyroid cancer, such as the advent of ultrasound and fine-needle aspiration, have enabled the detection of subclinical disease. Therefore, the increased incidence of thyroid cancer may reflect the identification of previously undetected disease with these improved diagnostic techniques, rather than a true increase in the occurrence of thyroid cancer [13,14]. Furthermore, due to the construction of a 1999-2009 KNCI DB, the completeness of the Korea cancer registry data has improved gradually, and this may have contributed, in part, to the gradual overall increases in cancer incidence, particularly among elderly patients. In particular, in 2009, colorectal cancer became the third most common cancer in females and for the first time ranked higher than stomach cancer, which had been the long-standing common cancer in Korea.
4. Age-specific incidence rates for selected cancer sites
Table 8 presents the most common cancer sites by sex and age group in 2009. Leukemia and thyroid cancer were the most common forms in both sexes for ages 0-14 and 15-34 years, respectively. For males, stomach cancer was the most common in 35-64-year-olds, while lung cancer was more frequent for patients aged ≥ 65 years. Thyroid cancer was the most common site for middle-aged Korean women (range, 35 to 64 years), and colorectal cancer was the most common among older women (range, ≥ 65 years).
Fig. 3 shows the age-specific incidence rates for selected cancers in males and females in 2009. The data show that the incidence of stomach, lung, liver, and colorectal cancers increased gradually with age. Incidence rates for breast and thyroid cancers in females were highest in women in their late 40s and early 50s, respectively, and leveled off thereafter. This pattern was very different from rates in Western countries [15].
5. Trends in cancer mortality
Figs. 1 and 4 show the trends in cancer deaths for all sites combined and for selected cancer sites. ASRs of mortality have decreased for all sites combined in both sexes since 2002. Lung cancer surpassed stomach cancer as the leading cause of cancer deaths in 1999 and is expected to account for 21.4% of all cancer deaths in 2009. The ASRs of mortality due to lung cancer have decreased slightly for men since 2001, but have increased in women. The ASRs of mortality due to stomach and cervical cancers have decreased continuously. The mortality rates of these cancers have also continued to increase along with the significant increases in colorectal, prostate, and female breast cancer incidence.
6. Survival rates
Table 9 shows the 5-year relative survivals for four periods of diagnosis: 1993-1995, 1996-2000, 2001-2005, and 2005-2009. Patients with cancer who were diagnosed in the recent period (2005-2009) had 5-year relative survival rates of 62.0% for all sites combined in both sexes (53.2% in males and 71.4% in females). When compared with earlier periods, notable improvements were observed in the 5-year relative survival rates for all sites combined. The observation of higher cancer survival rates in females than in males may be partly explained by common cancers in females (e.g., thyroid, breast, and uterine/cervical) that are known to have relatively good prognoses.
When examined by the year of diagnosis and cancer site, the 5-year relative survival rates appeared to be higher for most major cancer sites in patients diagnosed during 2005-2009 compared with 1993-1995, except for pancreatic cancer. The greatest improvements were seen in non-Hodgkin lymphoma, prostate, and stomach cancers, as well as leukemia. The improving survival rates could be attributable to early detection and improved treatments [16,17], but this requires further evaluation. A lack of progress in early detection and treatment could explain the observed absence of improvement in the survival rate for pancreatic cancer [18].
7. Prevalence rates
Table 10 shows the 10-year cancer prevalent rates on January 1, 2010 in Korea by sex and cancer site. The 10-year cancer prevalence CRs of all sites combined were 1,491.4 and 1,765.5 per 100,000 in males and females, respectively, and the 10-year cancer prevalence ASRs of all sites combined were 1,218.2 and 1,237.3 per 100,000 in males and females, respectively. In males, the five leading primary sites of cancer for prevalence were the stomach (CR, 389.6; ASR, 312.9), colon and rectum (CR, 275.6; ASR, 223.8), liver (CR, 117.9; ASR, 93.8), prostate (CR, 117.3; ASR, 99.2), and lung (CR, 102.8; ASR, 84.5), accounting for 67.3% of all cancer prevalent cases. In females, the most common cancer sites were the thyroid (CR, 470.4; ASR, 342.6), breast (CR, 349.2; ASR, 247.0), stomach (CR, 196.4; ASR, 128.5), colon and rectum (CR, 190.4; ASR, 123.4), cervix (CR, 131.5; ASR, 91.0), and lung (CR, 51.4; ASR, 33.3), accounting for 78.6% of all cancer prevalent cases.
Fig. 5 shows prevalence by time since diagnosis. For all cancers combined, the 1-2-year prevalence represented 36% of the total prevalent cases. The 1-2-year prevalence as a percentage of the total was highest for thyroid cancer (20%), followed by stomach (16%) and colorectal (14%) cancers, which had the high incidence rates and good prognoses. For all cancers combined, the 2- to 5-year and 5- to 10-year prevalence constituted 34% and 30% of the total prevalence in both sexes, respectively. The long-term prevalence of lung and liver cancers was relatively low due to lower survival rates.
Acknowledgements
This work was supported by a research grant from the National Cancer Center (No. 1010160) and National Health Promotion Program grants (Nos. 1160390 and 1160400) from the Ministry of Health and Welfare, Republic of Korea. The authors are indebted to the Korea Central Cancer Registry (KCCR)-affiliated hospitals, non-KCCR-affiliated hospitals, 11 regional cancer registries (Busan, Daegu & Gyeongbuk, Gwangju & Jeonnam, Incheon, Daejeon & Chungnam, Ulsan, Gangwon, Chungbuk, Jeonbuk, Gyeongnam, and Jejudo), the National Health Insurance Corporation, and Statistics Korea for data collection.

Conflict of interest relevant to this article was not reported.

  • 1. Statistics Korea, 2011 [Internet]. 2011. cited 2012 Jan 16Daejeon: Statistics Korea; Available from: http://kostat.go.kr
  • 2. Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Park EC, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat. 2011;43:1–11. PMID: 21509157ArticlePubMedPMCPDF
  • 3. Won YJ, Sung J, Jung KW, Kong HJ, Park S, Shin HR, et al. Nationwide cancer incidence in Korea, 2003-2005. Cancer Res Treat. 2009;41:122–131. PMID: 19809561ArticlePubMedPMCPDF
  • 4. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999~2001: first result using the national cancer incidence database. Cancer Res Treat. 2005;37:325–331. PMID: 19956367ArticlePubMedPMCPDF
  • 5. Ajiki W, Tsukuma H, Oshima A. Index for evaluating completeness of registration in population-based cancer registries and estimation of registration rate at the Osaka Cancer Registry between 1966 and 1992 using this index. Nihon Koshu Eisei Zasshi. 1998;45:1011–1017. PMID: 9893469PubMed
  • 6. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. 2000. 3rd ed. Geneva: World Health Organization.
  • 7. World Health OrganizationManual of the international statistical classification of diseases, injuries, and causes of death. 1992. 10th rev. Geneva: World Health Organization.
  • 8. Segi M. Cancer mortality for selected sites in 24 countries (1950-1957). 1960. Sendai: Tohoku University School of Medicine.
  • 9. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W. SEER cancer statistics review, 1975-2007. 2010. Bethesda, MD: National Cancer Institute.
  • 10. SEER*Stat Program, version 6.6.1 [Internet]. National Cancer Institute. 2011. cited 2011 Jan 14Bethsda, MD: National Cancer Institute; Available from: http://seer.cancer.gov/seerstat/
  • 11. Ederer F, Heise H. Instructions to IBM programmers in processing survival computations. Methodological note No. 10. 1959. Bethesda, MD: National Cancer Institute.
  • 12. Dickman P [Internet]. cited 2009 Apr 14Stockholm: PaulDickman.com; Available from: http://www.pauldickman.com
  • 13. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295:2164–2167. PMID: 16684987ArticlePubMed
  • 14. Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev. 2009;18:784–791. PMID: 19240234ArticlePubMedPMC
  • 15. Curado MP, Edwards B, Shin HR, Stom H, Ferlay J, Heanue M. Cancer incidence in five continents, vol. 9. 2007. Lyon: IARC.
  • 16. Jung KW, Yim SH, Kong HJ, Hwang SY, Won YJ, Lee JK, et al. Cancer survival in Korea 1993-2002: a population-based study. J Korean Med Sci. 2007;22(Suppl):S5–S10. PMID: 17923755ArticlePubMedPMC
  • 17. Gondos A, Bray F, Hakulinen T, Brenner H. EUNICE Survival Working GroupTrends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol. 2009;20:564–573. PMID: 19066327ArticlePubMed
  • 18. Dickman PW, Adami HO. Interpreting trends in cancer patient survival. J Intern Med. 2006;260:103–117. PMID: 16882274ArticlePubMed
Fig. 1
Annual age-standardized cancer incidence and death rates for all sites by sex during 1983-2009 in Korea. Age standardization was based on the World Health Organization world standard population.
crt-44-11-g001.jpg
Fig. 2
Trends in age-standardized cancer incidence for selected cancers by sex during 1999-2009 in Korea. Age standardization was based on the World Health Organization world standard population. (A) Male. (B) Female.
crt-44-11-g002.jpg
Fig. 3
Age-specific incidence rates for major cancers during 2009 in Korea. (A) Male. (B) Female.
crt-44-11-g003.jpg
Fig. 4
Annual age-standardized cancer mortality for selected cancers by gender during 1983-2009 in Korea. Age standardization was based on the World Health Organization world standard population. (A) Male. (B) Female.
crt-44-11-g004.jpg
Fig. 5
Number of prevalent cases by time since diagnosis for major cancer sites on January 1, 2010 in Korea.
crt-44-11-g005.jpg
Table 1
Number of cancer incidence cases, deaths, and prevalent cases by gender during 2009 in Korea
Sites New cases
Deaths
10-yr prevalent casesa)
Both genders Male Female Both genders Male Female Both genders Male Female
All sites 192,561 99,224 93,337 69,780 43,846 25,934 808,503 371,001 437,502
Lip, oral cavity, and pharynx 2,511 1,865 646 973 765 208 11,981 8,205 3,776
Esophagus 2,136 1,975 161 1,406 1,297 109 5,574 5,053 521
Stomach 29,727 19,953 9,774 10,135 6,680 3,455 145,589 96,919 48,670
Colon and rectum 24,986 15,068 9,918 7,051 3,929 3,122 115,741 68,566 47,175
Liver 15,936 11,913 4,023 11,246 8,429 2,817 38,920 29,331 9,589
Gallbladderb) 4,782 2,379 2,403 3,619 1,775 1,844 10,778 5,512 5,266
Pancreas 4,427 2,433 1,994 4,058 2,229 1,829 5,085 2,788 2,297
Larynx 1,148 1,082 66 424 382 42 6,635 6,233 402
Lung 19,685 14,026 5,659 14,919 10,892 4,027 38,313 25,580 12,733
Breast 13,460 61 13,399 1,893 15 1,878 86,922 397 86,525
Cervix uteri 3,733 - 3,733 950 - 950 32,582 - 32,582
Corpus uteri 1,732 - 1,732 221 - 221 9,982 - 9,982
Ovary 1,783 - 1,783 854 - 854 10,047 - 10,047
Prostate 7,351 7,351 - 1,235 1,235 - 29,183 29,183 -
Testis 200 200 - 23 23 - 1,472 1,472 -
Kidney 3,435 2,327 1,108 743 501 242 17,015 11,473 5,542
Bladder 3,203 2,550 653 965 709 256 19,051 15,486 3,565
Brain and CNS 1,653 893 760 1,065 558 507 6,498 3,422 3,076
Thyroid 31,977 5,162 26,815 352 111 241 136,388 19,833 116,555
Hodgkin lymphoma 220 146 74 41 28 13 1,364 869 495
Non-Hodgkin lymphoma 3,873 2,167 1,706 1,340 778 562 17,656 9,692 7,964
Multiple myeloma 1,020 568 452 701 374 327 2,731 1,446 1,285
Leukemia 2,687 1,496 1,191 1,541 855 686 10,554 5,819 4,735
Other and ill-defined 10,896 5,609 5,287 4,025 2,281 1,744 48,442 23,722 24,720

CNS, central nervous system. a)10-yr prevalent cases: limited-duration prevalent cases on January 1, 2010. These are patients that were diagnosed between January 1, 2000 and December 31, 2009 and were alive on January 1, 2010. Multiple primary cancer cases were counted multiple times, b)Includes gallbladder and other/unspecified parts of the biliary tract.

Table 2
Crude and age-standardized cancer incidence rates by gender during 2009 in Korea
Crude incidence rates/100,000 Sites
Age-standardized incidence rates/100,000a)
Both genders Male Female Both genders Male Female
All sites 387.8 398.9 376.7 282.0 325.5 259.3
Lip, oral cavity, and pharynx 5.1 7.5 2.6 3.7 6.0 1.8
Esophagus 4.3 7.9 0.6 3.1 6.5 0.4
Stomach 59.9 80.2 39.4 43.0 64.5 25.5
Colon and rectum 50.3 60.6 40.0 36.2 49.0 25.9
Liver 32.1 47.9 16.2 23.2 37.7 10.4
Gallbladderb) 9.6 9.6 9.7 6.7 8.0 5.7
Pancreas 8.9 9.8 8.0 6.2 8.0 4.8
Larynx 2.3 4.3 0.3 1.7 3.6 0.2
Lung 39.6 56.4 22.8 27.8 46.8 13.9
Breast 27.1 0.2 54.1 19.4 0.2 38.3
Cervix uteri 7.5 - 15.1 5.4 - 10.5
Corpus uteri 3.5 - 7.0 2.6 - 5.0
Ovary 3.6 - 7.2 2.7 - 5.2
Prostate 14.8 29.6 - 10.4 24.8 -
Testis 0.4 0.8 - 0.4 0.8 -
Kidney 6.9 9.4 4.5 5.1 7.5 3.1
Bladder 6.5 10.3 2.6 4.5 8.5 1.5
Brain and CNS 3.3 3.6 3.1 2.9 3.4 2.5
Thyroid 64.4 20.8 108.2 47.5 15.4 79.6
Hodgkin lymphoma 0.4 0.6 0.3 0.4 0.5 0.3
Non-Hodgkin lymphoma 7.8 8.7 6.9 6.0 7.3 5.0
Multiple myeloma 2.1 2.3 1.8 1.5 1.9 1.2
Leukemia 5.4 6.0 4.8 5.0 5.9 4.2
Other and ill-defined 21.9 22.5 21.3 16.5 19.3 14.3

CNS, central nervous system. a)Age adjusted to the World Health Organization world standard population, b)Includes gallbladder and other/unspecified parts of the biliary tract.

Table 3
Ten leading causes of death during 2009 in Korea
Rank Cause of death No. of deaths Percent of all deaths Age-standardized
death rates/100,000a)
All causes 246,942 100.0 349.5
1 Cancer 69,780 28.3 97.8
2 Cerebrovascular disease 25,838 10.5 34.2
3 Heart disease 22,347 9.0 30.3
4 Intentional self harm (suicide) 15,413 6.2 23.8
5 Diabetes mellitus 9,757 4.0 13.1
6 Transport accidents 7,147 2.9 11.5
7 Chronic lower respiratory diseases 6,914 2.8 9.0
8 Disease of liver 6,868 2.8 9.9
9 Pneumonia 6,324 2.6 8.4
10 Hypertensive diseases 4,749 1.9 6.3
Others 71,805 29.1 105.3

Source: Mortality Data, 2009, Korea National Statistical Office. a)Age adjusted to the World Health Organization world standard population.

Table 4
Crude and age-standardized cancer mortality rates by gender during 2009 in Korea
Sites Crude incidence rates/100,000 Sites
Age-standardized incidence rates/100,000a)
Both genders Male Female Both genders Male Female
All sites 140.5 176.3 104.7 97.8 146.7 62.9
Lip, oral cavity, and pharynx 2.0 3.1 0.8 1.4 2.5 0.5
Esophagus 2.8 5.2 0.4 2.0 4.3 0.2
Stomach 20.4 26.9 13.9 14 22.3 8.1
Colon and rectum 14.2 15.8 12.6 9.7 13.2 7.3
Liver 22.6 33.9 11.4 16.2 27.1 6.9
Gallbladderb) 7.3 7.1 7.4 4.9 6.0 4.1
Pancreas 8.2 9.0 7.4 5.6 7.4 4.2
Larynx 0.9 1.5 0.2 0.6 1.3 0.1
Lung 30.0 43.8 16.3 20.5 36.6 9.2
Breast 3.8 0.1 7.6 2.7 0.1 5.2
Cervix uteri 1.9 - 3.8 1.3 - 2.4
Corpus uteri 0.4 - 0.9 0.3 - 0.6
Ovary 1.7 - 3.4 1.2 - 2.3
Prostate 2.5 5.0 - 1.6 4.6 -
Testis 0.0 0.1 - 0.0 0.1 -
Kidney 1.5 2.0 1.0 1 1.6 0.6
Bladder 1.9 2.9 1.0 1.3 2.5 0.5
Brain and CNS 2.1 2.2 2.0 1.7 1.9 1.5
Thyroid 0.7 0.4 1.0 0.5 0.4 0.5
Hodgkin lymphoma 0.1 0.1 0.1 0.1 0.1 0.0
Non-Hodgkin lymphoma 2.7 3.1 2.3 1.9 2.6 1.4
Multiple myeloma 1.4 1.5 1.3 1.0 1.2 0.8
Leukemia 3.1 3.4 2.8 2.5 3.0 2.1
Other and ill-defined 8.1 9.2 7.0 5.8 7.8 4.3

CNS, central nervous system. a)Age adjusted to the World Health Organization world standard population, b)Includes gallbladder and other/unspecified parts of the biliary tract.

Table 5
Trends in cancer incidence rates in both sexes during 1999-2009 in Korea
Sites Year
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 APCa)
All sites 210.5 205.1 216.7 220.1 227.2 234.3 247.0 251.0 261.7 273.5 282.0 3.3b)
Lip, oral cavity, and pharynx 3.6 4.4 3.6 3.7 3.8 3.8 3.8 3.8 3.9 4.0 3.7 0.1
Esophagus 4.1 3.7 3.9 3.8 3.6 3.5 3.5 3.4 3.3 3.3 3.1 -2.2b)
Stomach 43.6 42.3 44.0 43.6 43.2 41.1 44.4 42.8 41.6 42.4 43.0 -0.2
Colon and rectum 20.4 21.0 22.9 24.7 26.8 28.5 30.8 32.3 33.4 34.4 36.2 6.2b)
Liver 27.9 26.7 27.3 26.5 25.7 25.5 25.8 24.5 24.3 23.9 23.2 -1.7b)
Gallbladderc) 6.5 6.4 6.7 6.7 6.7 6.9 7.1 6.6 6.5 6.4 6.7 0.1
Pancreas 5.6 5.5 5.5 5.8 5.8 6.0 6.3 6.2 6.3 6.4 6.2 1.6b)
Larynx 2.3 2.2 2.4 2.2 2.1 1.9 2.0 1.8 1.8 1.6 1.7 -3.6b)
Lung 28.5 27.7 28.3 28.5 27.8 28.8 28.9 28.6 28.3 28.0 27.8 0.0
Breast 10.7 10.8 12.7 13.9 14.2 14.9 16.2 16.9 18.0 18.8 19.4 6.3b)
Cervix uteri 8.5 7.9 8.3 7.7 7.4 6.8 6.4 6.3 5.7 5.8 5.4 -4.6b)
Corpus uteri 1.4 1.3 1.5 1.7 1.9 1.9 2.0 2.1 2.1 2.4 2.6 6.2b)
Ovary 2.7 2.5 2.5 2.6 2.7 2.7 2.8 2.8 3.0 2.8 2.7 1.2b)
Prostate 3.1 2.7 3.6 3.9 4.8 6.0 6.3 7.2 8.6 9.7 10.4 14.9b)
Testis 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4 3.9b)
Kidney 3.0 2.9 3.3 3.4 3.5 3.7 4.1 4.4 4.8 5.0 5.1 6.3b)
Bladde 4.6 4.6 4.9 4.7 5.1 5.1 5.1 4.9 5.0 4.8 4.5 0.1
Brain and CNS 2.9 2.8 2.8 2.6 2.9 2.9 3.0 2.9 3.1 3.0 2.9 0.8b)
Thyroid 6.3 6.1 7.9 9.5 12.7 17.2 20.6 25.4 32.7 41.2 47.5 24.9b)
Hodgkin lymphoma 0.2 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.4 0.4 0.4 4.5b)
Non-Hodgkin lymphoma 4.5 4.2 4.5 4.6 4.9 5.2 5.3 5.5 5.5 5.6 6.0 3.4b)
Multiple myeloma 1.0 1.0 1.1 1.1 1.1 1.2 1.3 1.3 1.4 1.4 1.5 4.1b)
Leukemia 4.7 4.3 4.7 4.8 4.7 4.8 4.7 4.9 4.8 5.0 5.0 1.0b)
Other and ill-defined 14.3 13.5 13.9 13.5 15.1 15.1 16.0 16.0 16.9 16.8 16.5 -

APC, annual percent change; CNS, central nervous system. a)APC using age-standardized incidence based on the World Health Organization world standard population, b)APC was significantly different from zero (p < 0.05), c)Includes gallbladder and other/unspecified parts of the biliary tract.

Table 6
Trends in cancer incidence rates in males during 1999-2009 in Korea
Sites Year
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 APCa)
All sites 285.0 276.7 288.3 290.0 294.4 298.8 310.6 309.2 315.2 321.2 325.5 1.6b)
Lip, oral cavity, and pharynx 6.1 7.1 6.0 6.2 6.5 6.1 6.0 6.1 6.3 6.4 6.0 -0.4
Esophagus 8.8 8.0 8.3 8.2 7.7 7.7 7.6 7.2 6.9 7.0 6.5 -2.6b)
Stomach 66.2 65.0 67.2 66.6 5.9 62.2 66.8 65.2 62.9 64.2 64.5 -0.4
Colon and rectum 26.2 27.2 29.6 32.9 35.2 37.8 41.0 43.1 45.0 46.3 49.0 6.8b)
Liver 46.8 44.7 45.1 43.9 42.3 42.1 42.6 40.2 39.6 39.2 37.7 -1.9b)
Gallbladderc) 8.1 7.8 8.2 8.1 7.8 8.4 8.7 8.1 7.9 7.6 8.0 -0.2
Pancreas 7.8 7.6 7.6 7.9 7.7 8.0 8.3 8.0 8.2 8.3 8.0 0.7b)
Larynx 4.9 4.5 5.1 4.7 4.5 4.1 4.3 3.7 3.8 3.5 3.6 -3.6b)
Lung 51.4 49.8 51.1 51.0 49.9 50.8 50.8 49.1 48.6 47.4 46.8 -0.8b)
Breast 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.1 0.3 0.2 -2.0
Prostate 8.4 7.2 9.5 10.1 12.4 15.0 15.7 17.9 20.8 23.3 24.8 13.4b)
Testis 0.6 0.5 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.7 0.8 3.8b)
Kidney 4.5 4.4 4.9 5.0 5.2 5.5 6.0 6.5 7.0 7.4 7.5 5.9b)
Bladder 9.0 9.0 9.4 9.0 9.7 9.8 9.8 9.6 9.3 9.1 8.5 -0.1
Brain and CNS 3.2 3.1 3.1 2.9 3.3 3.3 3.3 3.1 3.3 3.3 3.4 0.9b)
Thyroid 2.1 1.9 2.4 2.7 3.7 4.8 5.9 7.5 10.0 13.2 15.4 24.8b)
Hodgkin lymphoma 0.4 0.4 0.4 0.3 0.4 0.5 0.4 0.4 0.5 0.5 0.5 3.1b)
Non-Hodgkin lymphoma 5.8 5.5 5.8 5.8 6.2 6.6 6.4 6.8 7.0 6.7 7.3 2.6b)
Multiple myeloma 1.2 1.3 1.4 1.4 1.4 1.4 1.6 1.4 1.6 1.6 1.9 3.5b)
Leukemia 5.5 5.0 5.4 5.8 5.5 5.7 5.5 5.6 5.7 5.7 5.9 0.9b)
Other and ill-defined 17.9 16.5 16.8 16.5 18.4 18.1 19.1 18.7 20.0 19.5 19.3 -

APC, annual percent change; CNS, central nervous system. a)APC using age-standardized incidence based on the World Health Organization world standard population, b)APC was significantly different from zero (p < 0.05), c)Includes gallbladder and other/unspecified parts of the biliary tract.

Table 7
Trends in cancer incidence rates in females during 1999-2009 in Korea
Sites Year
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 APCa)
All sites 161.1 157.4 169.0 174.6 183.9 192.9 207.0 215.5 230.6 247.5 259.3 5.3b)
Lip, oral cavity, and pharynx 1.6 2.4 1.7 1.7 1.7 1.9 1.9 1.8 1.9 1.9 1.8 0.4
Esophagus 0.6 0.6 0.6 0.5 0.6 0.5 0.4 0.5 0.5 0.5 0.4 -2.9b)
Stomach 26.7 25.2 26.2 26.3 25.9 24.7 26.8 25.0 24.7 25.0 25.5 -0.5
Colon and rectum 16.4 16.4 17.9 18.8 20.5 21.4 22.9 23.9 24.4 24.9 25.9 5.1b)
Liver 12.3 11.8 12.2 11.8 11.5 11.3 11.3 11.1 11.0 10.6 10.4 -1.5b)
Gallbladderc) 5.3 5.5 5.7 5.8 5.8 5.9 6.0 5.5 5.6 5.5 5.7 0.2
Pancreas 4.0 4.0 4.0 4.2 4.4 4.5 4.7 4.7 4.7 4.9 4.8 2.3b)
Larynx 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.2 -8.5b)
Lung 12.4 12.5 12.3 12.6 12.4 13.0 13.5 14.0 13.9 14.1 13.9 1.5b)
Breast 20.9 20.9 24.7 27.2 27.8 29.2 31.8 33.1 35.4 37.0 38.3 6.5b)
Cervix uteri 16.3 15.1 15.8 14.8 14.2 13.1 12.3 12.2 11.0 11.3 10.5 6.4b)
Corpus uteri 2.8 2.6 3.0 3.3 3.8 3.7 3.9 4.0 4.2 4.7 5.0 -4.4b)
Ovary 5.0 4.8 4.8 5.0 5.1 5.2 5.4 5.4 5.9 5.5 5.2 1.4b)
Kidney 1.7 1.8 1.9 2.0 2.1 2.2 2.5 2.7 2.8 3.0 3.1 6.5b)
Bladder 1.6 1.6 1.7 1.7 1.8 1.7 1.7 1.6 1.7 1.6 1.5 -0.3
Brain and CNS 2.6 2.5 2.5 2.4 2.5 2.6 2.8 2.6 2.8 2.6 2.5 0.6
Thyroid 10.4 10.1 13.2 16.2 21.8 29.5 35.2 43.2 55.4 69.2 79.6 25.1b)
Hodgkin lymphoma 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3 6.7b)
Non-Hodgkin lymphoma 3.4 3.2 3.4 3.5 3.9 4.1 4.4 4.3 4.3 4.7 5.0 4.4b)
Multiple myeloma 0.8 0.8 0.9 0.8 1.0 1.0 1.2 1.1 1.2 1.2 1.2 5.0b)
Leukemia 3.9 3.8 4.1 4.0 4.1 4.1 4.0 4.4 4.1 4.3 4.2 1.0b)
Other and ill-defined 11.8 11.5 11.8 11.5 12.6 12.9 13.7 13.9 14.5 14.6 14.3 -

APC, annual percent change; CNS, central nervous system. a)APC using age-standardized incidence based on the World Health Organization world standard population, b)APC was significantly different from zero (p < 0.05), c)Includes gallbladder and other/unspecified parts of the biliary tract.

Table 8
Five major sites of cancer incidence by age group and gender during 2009 in Korea
Rank Age group (yr)
0-14 15-34 35-64 ≥65
Male
1 Leukemia Thyroid Stomach Lung
(5.0) (9.4) (95.8) (451.5)
2 Brain and CNS Stomach Colon and rectum Stomach
(2.4) (3.1) (71.1) (443.9)
3 Non-Hodgkin lymphoma Leukemia Liver Colon and rectum
(1.6) (3.0) (68.1) (340.7)
4 Kidney Colon and rectum Lung Prostate
(0.5) (2.7) (41.8) (268.2)
5 Testis Non-Hodgkin lymphoma Thyroid Liver
(0.4) (2.6) (35.9) (209.2)
Female
1 Leukemia Thyroid Thyroid Colon and rectum
(3.5) (52.1) (192.5) (171.0)
2 Brain and CNS Breast Breast Stomach
(1.7) (10.0) (102.8) (160.5)
3 Non-Hodgkin lymphoma Cervix uteri Stomach Lung
(1.1) (5.3) (42.2) (120.5)
4 Ovary Stomach Colon and rectum Thyroid
(0.8) (4.2) (41.6) (82.1)
5 Kidney, thyroid Colon and rectum Cervix uteri Liver
(0.3) , (0.3) (2.6) (22.0) (76.9)

CNS, central nervous system.

Table 9
Trends in the 5-yr relative survival rates (%) by year of diagnosis during 1993-2009 in Korea
Sites Both genders
Male
Female
1993-1995 1996-2000 2001-2005 2005-2009 Changea) 1993-1995 1996-2000 2001-2005 2005-2009 Changea) 1993-1995 1996-2000 2001-2005 2005-2009 Changea)
All sites 41.2 44.0 53.7 62.0 20.8 31.7 35.3 45.2 53.2 21.5 53.4 55.3 63.9 71.4 18.0
Lip, oral cavity, and pharynx 41.1 46.7 54.1 58.9 17.8 35.8 41.1 49.2 54.3 18.5 58.1 63.8 67.7 70.9 12.8
Esophagus 12.7 15.2 21.1 27.5 14.8 11.8 14.3 20.4 26.7 14.9 23.7 24.2 29.3 36.6 12.9
Stomach 42.8 46.6 57.7 65.3 22.5 43.0 46.9 58.4 65.9 22.9 42.6 46.0 56.3 64.0 21.4
Colon and rectum 54.8 58.0 66.6 71.3 16.5 55.3 59.0 68.5 73.2 17.9 54.2 56.8 64.1 68.7 14.5
Liver 10.7 13.2 20.1 25.1 14.4 9.9 12.9 20.0 25.1 15.2 13.6 14.2 20.3 25.1 11.5
Gallbladderb) 17.3 19.7 22.8 26.1 8.8 16.6 20.3 23.3 27.0 10.4 18.0 19.1 22.3 25.2 7.2
Pancreas 9.4 7.6 8.0 8.0 1.4 8.8 7.3 8.0 7.9 0.9 10.1 8.1 8.0 8.2 -1.9
Larynx 59.7 62.3 66.2 71.3 11.6 60.2 62.8 66.8 71.6 11.4 55.4 57.8 58.2 65.9 10.5
Lung 11.3 12.7 16.1 19.0 7.7 10.4 11.6 14.9 17.1 6.7 14.2 16.2 19.6 23.9 9.7
Breast 77.9 83.2 88.4 90.6 12.7 75.1 85.6 86.9 92.0 16.9 78.0 83.2 88.5 90.6 12.6
Cervix uteri 77.5 80.0 81.2 80.3 2.8 - - - - - 77.5 80.0 81.2 80.3 2.8
Corpus uteri 81.5 81.8 84.7 84.9 3.4 - - - - - 81.5 81.8 84.7 84.9 3.4
Ovary 58.7 58.9 61.3 60.2 1.5 - - - - - 58.7 58.9 61.3 60.2 1.5
Prostate 55.9 67.2 79.9 87.6 31.7 55.9 67.2 79.9 87.6 31.7 - - - - -
Testis 85.4 90.4 90.6 92.3 6.9 85.4 90.4 90.6 92.3 6.9 - - - - -
Kidney 62.0 66.1 73.3 77.1 15.1 60.8 64.4 72.7 77.2 16.4 64.5 69.7 74.4 76.8 12.3
Bladder 69.1 73.1 75.4 76.0 6.9 70.0 74.8 77.2 77.6 7.6 65.5 66.3 68.4 69.3 3.8
Brain and CNS 38.5 39.0 40.4 43.3 4.8 37.2 37.5 39.7 42.1 4.9 40.2 40.7 41.2 44.6 4.4
Thyroid 94.2 94.9 98.3 99.7 5.5 87.2 89.5 95.7 99.3 12.1 95.4 95.9 98.7 99.8 4.4
Hodgkin lymphoma 68.0 71.2 76.7 81.9 13.9 67.6 68.1 74.7 81.1 13.5 68.6 77.4 80.6 83.3 14.7
Non-Hodgkin lymphoma 46.6 50.8 59.8 64.2 17.6 45.3 48.9 58.0 62.3 17.0 48.7 53.5 62.3 66.6 17.9
Multiple myeloma 22.1 19.8 29.3 34.3 12.2 21.1 17.8 29.7 34.7 13.6 23.3 22.1 28.8 33.9 10.6
Leukemia 26.5 33.3 41.6 46.0 19.5 26.2 32.3 41.5 45.1 18.9 26.8 34.6 41.8 47.2 20.4
Other and ill-defined 42.1 45.9 55.4 62.6 20.5 37.4 42.4 51.8 58.9 21.5 47.4 50.0 59.4 66.4 19.0

CNS, central nervous system. a)Change in the 5-yr relative survival between 1993-1995 and 2005-2009 as a percentage, b)Includes gallbladder and other/unspecified parts of the biliary tract.

Table 10
Crude and age-standardized rates of 10-yr cancer prevalence on January 1, 2010 by gender during 2009 in Korea
Sites Crude 10-yr prevalent rates/100,000
Age-standardized 10-yr prevalent rates/100,000a)
Both genders Male Female Both genders Male Female
All sites 1,628.2 1,491.4 1,765.5 1,193.2 1,218.2 1,237.3
Lip, oral cavity, and pharynx 24.1 33.0 15.2 17.9 26.4 10.7
Esophagus 11.2 20.3 2.1 8.1 16.8 1.3
Stomach 293.2 389.6 196.4 211.1 312.9 128.5
Colon and rectum 233.1 275.6 190.4 167.4 223.8 123.4
Liver 78.4 117.9 38.7 58.2 93.8 26.7
Gallbladderb) 21.7 22.2 21.3 15.4 18.2 13.3
Pancreas 10.2 11.2 9.3 7.4 9.1 6.0
Larynx 13.4 25.1 1.6 9.7 20.7 1.0
Lung 77.2 102.8 51.4 55.5 84.5 33.3
Breast 175.0 1.6 349.2 125.9 1.3 247.0
Cervix uteri 65.6 - 131.5 47.0 - 91.0
Corpus uteri 20.1 - 40.3 14.9 - 29.1
Ovary 20.2 - 40.5 15.5 - 30.5
Prostate 58.8 117.3 - 40.2 99.2 -
Testis 3.0 5.9 - 2.8 5.4 -
Kidney 34.3 46.1 22.4 25.7 36.8 16.1
Bladder 38.4 62.3 14.4 26.8 51.5 8.6
Brain and CNS 13.1 13.8 12.4 11.8 12.7 10.9
Thyroid 274.7 79.7 470.4 201.7 59.6 342.6
Hodgkin lymphoma 2.7 3.5 2.0 2.4 3.0 1.8
Non-Hodgkin lymphoma 35.6 39.0 32.1 27.8 32.5 23.8
Multiple myeloma 5.5 5.8 5.2 4.0 4.7 3.5
Leukemia 21.3 23.4 19.1 21.0 23.4 18.7
Other and ill-defined 97.6 95.4 99.8 75.0 82.1 69.4

CNS, central nervous system. a)Age adjusted to the World Health Organization world standard population, b)Includes gallbladder and other/unspecified parts of the biliary tract.

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • Estrogen-related differences in antitumor immunity and gut microbiome contribute to sexual dimorphism of colorectal cancer
      Georgia Lattanzi, Federica Perillo, Angélica Díaz-Basabe, Bruna Caridi, Chiara Amoroso, Alberto Baeri, Elisa Cirrincione, Michele Ghidini, Barbara Galassi, Elisa Cassinotti, Ludovica Baldari, Luigi Boni, Maurizio Vecchi, Flavio Caprioli, Federica Facciott
      OncoImmunology.2024;[Epub]     CrossRef
    • Construction and validation of N6-methyladenosine long non-coding RNAs signature of prognostic value for early biochemical recurrence of prostate cancer
      Jingchao Liu, Wei Zhang, Jiawen Wang, Zhengtong Lv, Haoran Xia, Zhipeng Zhang, Yaoguang Zhang, Jianye Wang
      Journal of Cancer Research and Clinical Oncology.2023; 149(5): 1969.     CrossRef
    • Survival rate of thyroid cancer in the Asian countries: a systematic review and meta-analysis study
      Soheil Hassanipour, Reza Zare, Alireza Shahedi, Hamed Delam
      Endocrine.2023; 82(2): 237.     CrossRef
    • Changes in spatial clusters of cancer incidence and mortality over 15 years in South Korea: Implication to cancer control
      Cham Thi Nguyen, Insang Song, Inkyung Jung, Yoon‐Jung Choi, Sun‐Young Kim
      Cancer Medicine.2023; 12(16): 17418.     CrossRef
    • Cost-Effectiveness of Empirical Bismuth-Based Quadruple Therapy and Tailored Therapy After Clarithromycin Resistance Tests for Helicobacter pylori Eradication
      Young Woon Chang, Ga Young Shin, Jung-Wook Kim, Jin-Chang Moon, Eun Jee Chang, Chi Hyuk Oh, Jae-Young Jang
      Digestive Diseases and Sciences.2022; 67(4): 1222.     CrossRef
    • Disparities in utilization of robotic surgery for colon cancer: an evaluation of the U.S. National Cancer Database
      Michael L. Horsey, Debra Lai, Andrew D. Sparks, Aalap Herur-Raman, Marie Borum, Sanjana Rao, Matthew Ng, Vincent J. Obias
      Journal of Robotic Surgery.2022; 16(6): 1299.     CrossRef
    • Health Care Utilization and Anti-Cancer Drug Expenditure for Six Solid Cancers in Korea From 2007 to 2019
      Juhee Park, Kyeongjun Moon, Dong-Sook Kim
      Frontiers in Oncology.2022;[Epub]     CrossRef
    • Change of Voice Parameters After Thyroidectomy Without Apparent Injury to the Recurrent Laryngeal or External Branch of Superior Laryngeal Nerve: A Prospective Cohort Study
      Doh Young Lee, Goun Choe, Hanaro Park, Sungjun Han, Sung Joon Park, Seong Dong Kim, Bo Hae Kim, Young Ju Jin, Kyu Eun Lee, Young Joo Park, Tack-Kyun Kwon
      Journal of The Korean Society of Laryngology, Phoniatrics and Logopedics.2022; 33(2): 89.     CrossRef
    • Impact of hospital volume on people with disability and outcomes for cancer surgery
      Kyoung Eun Yeob, So Young Kim, Jin Pyo Lee, Jong Eun Park, Jong Hyock Park
      Surgery.2022; 172(6): 1866.     CrossRef
    • Clinical characteristics and survival of colorectal cancer patients in Korea stratified by age
      Sun Kyung Baek, Ji Sung Lee, In Gyu Hwang, Jong Gwang Kim, Tae Won Kim, Seung Kook Sohn, Mi Yeon Kang, Sang-Cheol Lee
      The Korean Journal of Internal Medicine.2021; 36(4): 985.     CrossRef
    • Are there modifiable risk factors affecting the prevalence of gallbladder polyps or those 5 mm or larger? A retrospective cross-sectional study
      Oh-Sung Kwon, Young-Kyu Kim
      Medicine.2021; 100(35): e27115.     CrossRef
    • Risk Factors for Tumor Size Increase During Active Surveillance of Papillary Thyroid Cancer: Meta-Analysis and Systematic Review
      Doh Young Lee, Pilkeun Jang
      Korean Journal of Otorhinolaryngology-Head and Neck Surgery.2021; 64(12): 914.     CrossRef
    • Survival Rate of Prostate Cancer in Asian Countries: A Systematic Review and Meta-Analysis
      Soheil Hassanipour, Hamed Delam, Morteza Arab-Zozani, Elham Abdzadeh, Seyyed Ali Hosseini, Hossein-Ali Nikbakht, Mahdi Malakoutikhah, Mohammad Taghi Ashoobi, Mohammad Fathalipour, Hamid Salehiniya, Shirin Riahi
      Annals of Global Health.2020; 86(1): 2.     CrossRef
    • Pretransplant Hepatic Malignancy Increases Risk of De Novo Malignancy after Liver Transplantation
      Gil-Chun Park, Shin Hwang, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Young-In Yoon, Hui-Dong Cho, Jae-Hyun Kwon, Yong-Kyu Chung, Sang-Hyun Kang, Jin-Uk Choi, I-Ji Jung, Sung-Gyu Lee
      Journal of Korean Medical Science.2020;[Epub]     CrossRef
    • Occupational Class and Cancer Survival in Korean Men: Follow-Up Study of Nation-Wide Working Population
      Hye-Eun Lee, Masayoshi Zaitsu, Eun-A Kim, Ichiro Kawachi
      International Journal of Environmental Research and Public Health.2020; 17(1): 303.     CrossRef
    • Cancer Incidence by Occupation in Korea: Longitudinal Analysis of a Nationwide Cohort
      Hye-Eun Lee, Masayoshi Zaitsu, Eun-A Kim, Ichiro Kawachi
      Safety and Health at Work.2020; 11(1): 41.     CrossRef
    • The Effect of Disability on the Diagnosis and Treatment of Multiple Myeloma in Korea: A National Cohort Study
      Jihyun Kwon, So Young Kim, Kyoung Eun Yeob, Hye Sook Han, Ki Hyeong Lee, Dong Wook Shin, Yeon-Yong Kim, Jong Heon Park, Jong Hyock Park
      Cancer Research and Treatment.2020; 52(1): 1.     CrossRef
    • Dietary Mixed Cereal Grains Ameliorate the Azoxymethane and Dextran Sodium Sulfate-Induced Colonic Carcinogenesis in C57BL/6J Mice
      Jia-Le Song, Jung-Sook Lee, Hee-Young Kim, Byung-Jin Jeong, Jong-Sung Jeong, Tae-Gon Huh, Kun-Young Park
      Journal of Medicinal Food.2020; 23(4): 440.     CrossRef
    • Characterization of the prognostic values and response to immunotherapy/chemotherapy of Krüppel‐like factors in prostate cancer
      Jialin Meng, Xiaofan Lu, Yujie Zhou, Meng Zhang, Lei Gao, Shenglin Gao, Fangrong Yan, Chaozhao Liang
      Journal of Cellular and Molecular Medicine.2020; 24(10): 5797.     CrossRef
    • Effects of probiotics or broccoli supplementation on Helicobacter pylori eradication with standard clarithromycin-based triple therapy
      Young Woon Chang, Yoo Min Park, Chi Hyuk Oh, Shin Ju Oh, Jun-Hyung Cho, Jung-Wook Kim, Jae-Young Jang
      The Korean Journal of Internal Medicine.2020; 35(3): 574.     CrossRef
    • Development and validation of a six-RNA binding proteins prognostic signature and candidate drugs for prostate cancer
      Lei Gao, Jialin Meng, Yong Zhang, Junfei Gu, Zhenwei Han, Xiaolu Wang, Shenglin Gao
      Genomics.2020; 112(6): 4980.     CrossRef
    • Clinicopathological features of colorectal polyps in 2002 and 2012
      Yoon Jeong Nam, Kyeong Ok Kim, Chan Seo Park, Si Hyung Lee, Byung Ik Jang
      The Korean Journal of Internal Medicine.2019; 34(1): 65.     CrossRef
    • Kolorektal kanserlerde E-kaderin ekspresyonunun prognostik belirteçlerle karşılaştırılması
      MEHMET ZENGIN
      Ortadoğu Tıp Dergisi.2019;[Epub]     CrossRef
    • Apatinib regulates the cell proliferation and apoptosis of liver cancer by regulation of VEGFR2/STAT3 signaling
      Song Wen, Guoliang Shao, Jiaping Zheng, Hui Zeng, Jun Luo, Danlin Gu
      Pathology - Research and Practice.2019; 215(4): 816.     CrossRef
    • Analysis of Mortality and Survival Rate of Liver Cancer in Zhejiang Province in China: A General Population-Based Study
      Fang-Rong Fei, Ru-Ying Hu, Wei-Wei Gong, Jin Pan, Meng Wang
      Canadian Journal of Gastroenterology and Hepatology.2019; 2019: 1.     CrossRef
    • The burden of leukemia in the Kingdom of Saudi Arabia: 15 years period (1999–2013)
      Amen Bawazir, Nouf Al-Zamel, Abeer Amen, Maaged A. Akiel, Naif M. Alhawiti, Ali Alshehri
      BMC Cancer.2019;[Epub]     CrossRef
    • The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer
      Jialin Meng, Yi Liu, Shiyang Guan, Song Fan, Jun Zhou, Meng Zhang, Chaozhao Liang
      Cancer Medicine.2019; 8(11): 5202.     CrossRef
    • Shared decision making and cancer screening
      Filipe Prazeres, Elisa Martins
      Indian Journal of Cancer.2019; 56(3): 195.     CrossRef
    • Macrometastasis in Papillary Thyroid Cancer Patients is Associated with Higher Recurrence in Lateral Neck Nodes
      Soo Young Kim, Bup‐Woo Kim, Ju Yeon Pyo, Soon Won Hong, Hang‐Seok Chang, Cheong Soo Park
      World Journal of Surgery.2018; 42(1): 123.     CrossRef
    • Microsatellite Alterations and Protein Expression of 5 Major Tumor Suppressor Genes in Gastric Adenocarcinomas
      Won Hyuk Choi, Sookhyun Lee, Sungjin Cho
      Translational Oncology.2018; 11(1): 43.     CrossRef
    • Temporal improvement in survival of patients with hepatocellular carcinoma in a hepatitis B virus‐endemic population
      Bo Hyun Kim, Young‐Suk Lim, Eun‐Yang Kim, Hyun‐Joo Kong, Young‐Joo Won, Seungbong Han, Sohee Park, Jae Seok Hwang
      Journal of Gastroenterology and Hepatology.2018; 33(2): 475.     CrossRef
    • Characteristics and Survival of Korean Patients With Colorectal Cancer Based on Data From the Korea Central Cancer Registry Data
      Hyuk Hur, Chang-Mo Oh, Young-Joo Won, Jae Hwan Oh, Nam Kyu Kim
      Annals of Coloproctology.2018; 34(4): 212.     CrossRef
    • Oncological treatment and outcome of colorectal cancer in Greenland
      Marie Odgaard, Nicolai Lohse, Alice Juhl Petersen, Lene Bæksgaard
      International Journal of Circumpolar Health.2018; 77(1): 1546069.     CrossRef
    • Robotic oesophago-gastric cancer surgery
      YA Qureshi, B Mohammadi
      The Annals of The Royal College of Surgeons of England.2018; 100(6_sup): 27.     CrossRef
    • Clinical manifestations and risk factors of anastomotic leakage after low anterior resection for rectal cancer
      Jung‐A Yun, Yong Beom Cho, Yoon Ah Park, Jung Wook Huh, Seong Hyeon Yun, Hee Cheol Kim, Woo Yong Lee, Ho‐Kyung Chun
      ANZ Journal of Surgery.2017; 87(11): 908.     CrossRef
    • Cancer, Stress, and Ironies of Cancer Understanding in South Korea
      Laura C. Nelson
      Medical Anthropology.2017; 36(1): 19.     CrossRef
    • Analysis of Temporal Change in Voice Quality After Thyroidectomy: Single-institution Prospective Study
      Doh Young Lee, Ki Jeong Lee, Soo Min Hwang, Kyoung Ho Oh, Jae-Gu Cho, Seung-Kuk Baek, Soon-Young Kwon, Jeong-Soo Woo, Kwang-Yoon Jung
      Journal of Voice.2017; 31(2): 195.     CrossRef
    • Prognostic Value of Tumor-to-Blood Standardized Uptake Ratio in Patients with Resectable Non-Small-Cell Lung Cancer
      Seunghyeon Shin, Kyoungjune Pak, In Joo Kim, Bum Soo Kim, Seong Jang Kim
      Nuclear Medicine and Molecular Imaging.2017; 51(3): 233.     CrossRef
    • Perceived needs for the information communication technology (ICT)‐based personalized health management program, and its association with information provision, health‐related quality of life (HRQOL), and decisional conflict in cancer patients
      Jin Ah Sim, Yoon Jung Chang, Aesun Shin, Dong‐Young Noh, Wonshik Han, Han‐Kwang Yang, Young Whan Kim, Young Tae Kim, Seoung‐Yong Jeong, Jung‐Hwan Yoon, Yoon Jun Kim, Daesuk Heo, Tae‐You Kim, Do‐Youn Oh, Hong‐Gyun Wu, Hak Jae Kim, Eui Kyu Chie, Keon Wook K
      Psycho-Oncology.2017; 26(11): 1810.     CrossRef
    • Advanced Colonic Neoplasia at Follow-up Colonoscopy According to Risk Components and Adenoma Location at Index Colonoscopy: A Retrospective Study of 1,974 Asymptomatic Koreans
      Su Jung Baik, Hyojin Park, Jae Jun Park, Hyun Ju Lee, So Young Jo, Yoo Mi Park, Hye Sun Lee
      Gut and Liver.2017; 11(5): 667.     CrossRef
    • Prophylactic perihepatic lymphadenectomy in patients with colorectal cancer with liver metastasis: A prospective preliminary study
      Jeong Heum Baek, Keon‐Kuk Kim, Jung‐Nam Lee, Seung‐Yeon Ha, Woon Kee Lee, Won‐Suk Lee
      Surgical Practice.2017; 21(4): 155.     CrossRef
    • Establishment of Korean prostate cancer database by the Korean Urological Oncology Society
      Hanjong Ahn, Hyung Jin Kim, Seong Soo Jeon, Cheol Kwak, Gyung Tak Sung, Tae Gyun Kwon, Jong Yeon Park, Sung Hyun Paick
      Investigative and Clinical Urology.2017; 58(6): 434.     CrossRef
    • Is methylation analysis ofSFRP2,TFPI2,NDRG4, andBMP3promoters suitable for colorectal cancer screening in the Korean population?
      Soo-Kyung Park, Hae Lim Baek, Junghee Yu, Ji Yeon Kim, Hyo-Joon Yang, Yoon Suk Jung, Kyu Yong Choi, Hungdai Kim, Hyung Ook Kim, Kyung Uk Jeong, Ho-Kyung Chun, Kyungeun Kim, Dong Il Park
      Intestinal Research.2017; 15(4): 495.     CrossRef
    • Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review
      Andrew D. Spence, Chris R. Cardwell, Úna C. McMenamin, Blanaid M. Hicks, Brian T. Johnston, Liam J. Murray, Helen G. Coleman
      BMC Gastroenterology.2017;[Epub]     CrossRef
    • Open radical prostatectomy reproducing robot-assisted radical prostatectomy: Involving antegrade nerve sparing and continuous anastomosis
      Se Yun Kwon, Jun Nyung Lee, Yun-Sok Ha, Seock Hwan Choi, Tae-Hwan Kim, Tae Gyun Kwon
      International braz j urol.2017; 43(6): 1043.     CrossRef
    • Young adulthood and adulthood adiposity in relation to incidence of pancreatic cancer: a prospective study of 0.5 million Chinese adults and a meta-analysis
      Yuanjie Pang, Michael V Holmes, Christiana Kartsonaki, Yu Guo, Ling Yang, Zheng Bian, Yiping Chen, Fiona Bragg, Andri Iona, Iona Y Millwood, Junshi Chen, Liming Li, Zhengming Chen
      Journal of Epidemiology and Community Health.2017; 71(11): 1059.     CrossRef
    • KLF15 promotes the proliferation and metastasis of lung adenocarcinoma cells and has potential as a cancer prognostic marker
      Lihua Gao, Hongmei Qiu, Jian Liu, Yuzhen Ma, Jia Feng, Li Qian, Jianguo Zhang, Yifei Liu, Tingting Bian
      Oncotarget.2017; 8(66): 109952.     CrossRef
    • Prognostic significance of perineural invasion in stage IIA colon cancer
      Jung‐A Yun, Hee Cheol Kim, Seok‐Hyung Kim, Yong Beom Cho, Seong Hyeon Yun, Woo Yong Lee, Ho‐Kyung Chun
      ANZ Journal of Surgery.2016; 86(12): 1007.     CrossRef
    • Investigation of cancer mortality inequalities between rural and urban areas in South Korea
      Kyung‐Mee Choi
      Australian Journal of Rural Health.2016; 24(1): 61.     CrossRef
    • Curcumin induces apoptosis by inhibiting sarco/endoplasmic reticulum Ca2+ ATPase activity in ovarian cancer cells
      Jeong-ah Seo, Boyun Kim, Danny N. Dhanasekaran, Benjamin K. Tsang, Yong Sang Song
      Cancer Letters.2016; 371(1): 30.     CrossRef
    • TROP2 overexpression promotes proliferation and invasion of lung adenocarcinoma cells
      Zanhua Li, Xunsheng Jiang, Wei Zhang
      Biochemical and Biophysical Research Communications.2016; 470(1): 197.     CrossRef
    • Clinical Significance of Peroxisome Proliferator-Activated Receptor γ and TRAP220 in Patients with Operable Colorectal Cancer
      Kyung A Kwon, Jeanho Yun, Sung Yong Oh, Bong-Gun Seo, Suee Lee, Ji-Hyun Lee, Sung-Hyun Kim, Hong Jo Choi, Mee Sook Roh, Hyo-Jin Kim
      Cancer Research and Treatment.2016; 48(1): 198.     CrossRef
    • Medical Costs and Healthcare Utilization among Cancer Decedents in the Last Year of Life in 2009
      Inuk Hwang, Dong Wook Shin, Kyoung Hee Kang, Hyung Kook Yang, So Young Kim, Jong-Hyock Park
      Cancer Research and Treatment.2016; 48(1): 365.     CrossRef
    • Colorectal Cancer Incidence in Korea Is Not the Highest in the World
      Aesun Shin, Kyu-Won Jung, Hyeongtaek Woo, Seung-Yong Jeong
      Cancer Research and Treatment.2016; 48(2): 864.     CrossRef
    • The Clinical Status of Radiation Therapy in Korea in 2009 and 2013
      Jin-Kyu Kang, Mi-Sook Kim, Won-Il Jang, Hee Jin Kim, Chul Koo Cho, Hyung Jun Yoo, Young Seok Seo, Eun Kyung Paik, Yu Jin Cha
      Cancer Research and Treatment.2016; 48(3): 892.     CrossRef
    • Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin)
      Seung Tae Kim, Soomin Ahn, Jeeyun Lee, Su Jin Lee, Se Hoon Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Kyoung-Mee Kim, Joon Oh Park
      Journal of Cancer Research and Clinical Oncology.2016; 142(6): 1231.     CrossRef
    • Age-Period-Cohort Analysis of Liver Cancer Mortality in Korea
      Jihwan Park, Yon Ho Jee
      Asian Pacific Journal of Cancer Prevention.2016; 16(18): 8589.     CrossRef
    • Single Port Gastrectomy for Gastric Cancer
      Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim
      The Journal of Minimally Invasive Surgery.2016; 19(2): 45.     CrossRef
    • The clinical utilization of radiation therapy in Korea between 2009 and 2013
      Jin-Kyu Kang, Mi-Sook Kim, Won-Il Jang, Young Seok Seo, Hee Jin Kim, Chul Koo Cho, Hyung Jun Yoo, Eun Kyung Paik, Yu Jin Cha, Hyun Jin Song
      Radiation Oncology Journal.2016; 34(2): 88.     CrossRef
    • Global methylation profiling to identify epigenetic signature of gallbladder cancer and gallstone disease
      Preeti Sharma, Shushruta Bhunia, Satish S. Poojary, Dinesh S. Tekcham, Mustafa Ahmed Barbhuiya, Sanjiv Gupta, Braj Raj Shrivastav, Pramod Kumar Tiwari
      Tumor Biology.2016; 37(11): 14687.     CrossRef
    • The Largest Known Survival Analysis of Patients with Brain Metastasis from Thyroid Cancer Based on Prognostic Groups
      Jinhyun Choi, Jun Won Kim, Yo Sup Keum, Ik Jae Lee, Bart O. Williams
      PLOS ONE.2016; 11(4): e0154739.     CrossRef
    • Dysregulation of MicroRNA-196b-5p and MicroRNA-375 in Gastric Cancer
      Seung Woo Lee, Ki Cheol Park, Jeong Goo Kim, Sung Jin Moon, Sang Bum Kang, Dong Soo Lee, Hae Joung Sul, Jeong Seon Ji, Hyun Yong Jeong
      Journal of Gastric Cancer.2016; 16(4): 221.     CrossRef
    • The Effect of Sex on the Azoxymethane/Dextran Sulfate Sodium-treated Mice Model of Colon Cancer
      Sun Min Lee, Nayoung Kim, Hee Jin Son, Ji Hyun Park, Ryoung Hee Nam, Min Hee Ham, Daeun Choi, Sung Hwa Sohn, Eun Shin, Young-Jae Hwang, Jihee Sung, Dong Ho Lee, Ha-Na Lee
      Journal of Cancer Prevention.2016; 21(4): 271.     CrossRef
    • Postoperative Adhesion after Thyroid Surgery
      Young Min Kim, Su-jin Kim, Jin Wook Yi, Chan-Yong Seong, Jong-Kyu Kim, Hyeong Won Yu, Young Jun Chai, June Young Choi, Kyu Eun Lee
      Korean Journal of Endocrine Surgery.2016; 16(4): 94.     CrossRef
    • Postoperative Adhesion after Thyroid Surgery
      Young Min Kim, Su-jin Kim, Jin Wook Yi, Chan-Yong Seong, Jong-Kyu Kim, Hyeong Won Yu, Young Jun Chai, June Young Choi, Kyu Eun Lee
      Korean Journal of Endocrine Surgery.2016; 16(4): 94.     CrossRef
    • Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer
      Seung Tae Kim, Jeeyun Lee, Su Jin Lee, Se Hoon Park, Sin-Ho Jung, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Joon Oh Park
      Oncotarget.2016; 7(17): 24088.     CrossRef
    • Simvastatin induces heme oxygenase-1 via NF-E2-related factor 2 (Nrf2) activation through ERK and PI3K/Akt pathway in colon cancer
      Hyun Joo Jang, Eun Mi Hong, Mikang Kim, Jae Hyun Kim, Juah Jang, Se Woo Park, Hyun Wu Byun, Dong Hee Koh, Min Ho Choi, Sea Hyub Kae, Jin Lee
      Oncotarget.2016; 7(29): 46219.     CrossRef
    • Effect of Different Iodine Concentrations on Well-Differentiated Thyroid Cancer Cell Behavior and its Inner Mechanism
      Jun Xiang, Xuemei Wang, Zhuoying Wang, Yi Wu, Duanshu Li, Qiang Shen, Tuanqi Sun, Qing Guan, Yunjun Wang
      Cell Biochemistry and Biophysics.2015; 71(1): 299.     CrossRef
    • A retrospective review of cutaneous metastases at the National Skin Centre Singapore
      Emily Yiping Gan, Martin Tze‐Wei Chio, Wee Ping Tan
      Australasian Journal of Dermatology.2015; 56(1): 1.     CrossRef
    • The NanoString-based multigene assay as a novel platform to screen EGFR, HER2, and MET in patients with advanced gastric cancer
      S. T. Kim, I.-G. Do, J. Lee, I. Sohn, K.-M. Kim, W. K. Kang
      Clinical and Translational Oncology.2015; 17(6): 462.     CrossRef
    • A Clinical Analysis of Brain Metastasis in Gynecologic Cancer: A Retrospective Multi-institute Analysis
      Young Zoon Kim, Jae Hyun Kwon, Soyi Lim
      Journal of Korean Medical Science.2015; 30(1): 66.     CrossRef
    • Lower maximum standardized uptake value of fluorine-18 fluorodeoxyglucose positron emission tomography coupled with computed tomography imaging in pancreatic ductal adenocarcinoma patients with diabetes
      Kwang Hyun Chung, Joo Kyung Park, Sang Hyub Lee, Dae Wook Hwang, Jai Young Cho, Yoo-Seok Yoon, Ho-Seong Han, Jin-Hyeok Hwang
      The American Journal of Surgery.2015; 209(4): 709.     CrossRef
    • High liver fibrosis index FIB‐4 is highly predictive of hepatocellular carcinoma in chronic hepatitis B carriers
      Beomseok Suh, Sehhoon Park, Dong Wook Shin, Jae Moon Yun, Hyung‐Kook Yang, Su Jong Yu, Cheong‐Il Shin, Jin‐Soo Kim, Eunmi Ahn, Hyejin Lee, Jin Ho Park, BeLong Cho
      Hepatology.2015; 61(4): 1261.     CrossRef
    • Role of charcoal tattooing in localization of recurred papillary thyroid carcinoma: initial experiences
      Hyungju Kwon, Soon Young Tae, Su-Jin Kim, Kyeong Cheon Jung, Ji-Hoon Kim, Kyu Eun Lee, Yeo-Kyu Youn
      Annals of Surgical Treatment and Research.2015; 88(3): 140.     CrossRef
    • Public-health impact of outdoor air pollution for 2nd air pollution management policy in Seoul metropolitan area, Korea
      Jong Han Leem, Soon Tae Kim, Hwan Cheol Kim
      Annals of Occupational and Environmental Medicine.2015;[Epub]     CrossRef
    • Characteristics of attitude and recommendation of oncologists toward exercise in South Korea: a cross sectional survey study
      Ji-Hye Park, Minsuk Oh, Yong Jin Yoon, Chul Won Lee, Lee W Jones, Seung Il Kim, Nam Kyu Kim, Justin Y Jeon
      BMC Cancer.2015;[Epub]     CrossRef
    • Predictors of Breast Self Examination Practice among North Korean Immigrant Women
      Mi Yeul Hyun, Hyo Jeong Song, Eun Joo Lee, Seong Chul Hong, Sung Yob Kim, Chang Hyun Lee
      Korean Journal of Health Promotion.2015; 15(1): 9.     CrossRef
    • Clinicopathological Characteristics of Serrated Polyposis Syndrome in Korea: Single Center Experience
      Hyung-Keun Kim, Kyung-Jin Seo, Hyun Ho Choi, Sung Soo Kim, Hiun-Suk Chae, Ok-Ran Shin, Chang Hyuck Ahn, Young-Seok Cho
      Gastroenterology Research and Practice.2015; 2015: 1.     CrossRef
    • The Economic Burden of Cancer in Korea in 2009
      So Young Kim, Jong-Hyock Park, Kyoung Hee Kang, Inuk Hwang, Hyung Kook Yang, Young-Joo Won, Hong-Gwan Seo, Dukhyoung Lee, Seok-Jun Yoon
      Asian Pacific Journal of Cancer Prevention.2015; 16(3): 1295.     CrossRef
    • Incidence of kidney, bladder, and prostate cancers in Korea: An update
      Wan Song, Hwang Gyun Jeon
      Korean Journal of Urology.2015; 56(6): 422.     CrossRef
    • Therapeutic effect of Active Hexose-Correlated Compound (AHCC) combined with CpG-ODN (oligodeoxynucleotide) in B16 melanoma murine model
      Rosa Mistica Ignacio, Cheol-Su Kim, Young-Do Kim, Hak-Min Lee, Xu-Feng Qi, Soo-Ki Kim
      Cytokine.2015; 76(2): 131.     CrossRef
    • The Effects of Broccoli Sprout Extract Containing Sulforaphane on Lipid Peroxidation and Helicobacter pylori Infection in the Gastric Mucosa
      Young Woon Chang, Jae Young Jang, Yong Ho Kim, Jung-Wook Kim, Jae-Jun Shim
      Gut and Liver.2015; 9(4): 486.     CrossRef
    • Comparison of Social Nicotine Dependence Using the KTSND-K Questionnaire between patients with lung cancer and non-cancer people
      Jin Young Lee, Chul Ho Oak, Tae Won Jang, Maan Hong Jung, Seong Jin Nam, Su Kyung Son, Ji Hyun Lee, Eun Joo Jo, Sang Joon Lee
      Kosin Medical Journal.2015; 30(1): 51.     CrossRef
    • Prediction of future hepatocellular carcinoma incidence in moderate to heavy alcohol drinkers with the FIB‐4 liver fibrosis index
      Beomseok Suh, Jae Moon Yun, Sehhoon Park, Dong Wook Shin, Tae Hoon Lee, Hyung‐Kook Yang, Eunmi Ahn, Hyejin Lee, Jin Ho Park, BeLong Cho
      Cancer.2015; 121(21): 3818.     CrossRef
    • Preoperative neutrophil-to-lymphocyte ratio is a prognostic factor for overall survival in patients with gastric cancer
      Jeong Hwan Kim, Dong-Seok Han, Ho Yoon Bang, Pyeong Su Kim, Kyung-Yung Lee
      Annals of Surgical Treatment and Research.2015; 89(2): 81.     CrossRef
    • The Clinical Significance of the Right Para-Oesophageal Lymph Nodes in Papillary Thyroid Cancer
      Hojin Chang, Ri Na Yoo, Seok-Mo Kim, Bup-Woo Kim, Yong Sang Lee, Seung Chul Lee, Hang-Seok Chang, Cheong Soo Park
      Yonsei Medical Journal.2015; 56(6): 1632.     CrossRef
    • Reliability and Validity of the Korean Version of the Modified Adult Attachment Scale for the Use of Medically Ill Patients
      Byunggu Jang, Hyo-Deog Rim, Jungmin Woo
      Psychiatry Investigation.2015; 12(4): 483.     CrossRef
    • Incidence, Trends and Epidemiology of Cancers in North West of Iran
      Atefeh Zahedi, Hosein Rafiemanesh, Mostafa Enayatrad, Mahshid Ghoncheh, Hamid Salehiniya
      Asian Pacific Journal of Cancer Prevention.2015; 16(16): 7189.     CrossRef
    • HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells
      MEIYING JI, EUN JEOUNG LEE, KI BAE KIM, YANGMI KIM, ROHYUN SUNG, SANG-JEON LEE, DON SOO KIM, SEON MEE PARK
      Oncology Reports.2015; 33(5): 2299.     CrossRef
    • Survival Nomogram for Curatively Resected Korean Gastric Cancer Patients: Multicenter Retrospective Analysis with External Validation
      Bang Wool Eom, Keun Won Ryu, Byung-Ho Nam, Yunjin Park, Hyuk-Joon Lee, Min Chan Kim, Gyu Seok Cho, Chan Young Kim, Seung Wan Ryu, Dong Woo Shin, Woo Jin Hyung, Jun Ho Lee, Qing-Yi Wei
      PLOS ONE.2015; 10(2): e0119671.     CrossRef
    • Prediction Model for Gastric Cancer Incidence in Korean Population
      Bang Wool Eom, Jungnam Joo, Sohee Kim, Aesun Shin, Hye-Ryung Yang, Junghyun Park, Il Ju Choi, Young-Woo Kim, Jeongseon Kim, Byung-Ho Nam, Masaru Katoh
      PLOS ONE.2015; 10(7): e0132613.     CrossRef
    • A Clinical Analysis of Endoscopic Thyroidectomy via Bilateral Axillo-breast Approach: A 5-year Experience
      Yun Chul Park, Young Jae Ryu, Jin Seong Cho, Jung Han Yoon, Min Ho Park
      Korean Journal of Endocrine Surgery.2015; 15(2): 41.     CrossRef
    • A Clinical Analysis of Endoscopic Thyroidectomy via Bilateral Axillo-breast Approach: A 5-year Experience
      Yun Chul Park, Young Jae Ryu, Jin Seong Cho, Jung Han Yoon, Min Ho Park
      Korean Journal of Endocrine Surgery.2015; 15(2): 41.     CrossRef
    • Sex- and gender-specific disparities in colorectal cancer risk
      Sung-Eun Kim
      World Journal of Gastroenterology.2015; 21(17): 5167.     CrossRef
    • Vegetable Intake, but Not Fruit Intake, Is Associated with a Reduction in the Risk of Cancer Incidence and Mortality in Middle-Aged Korean Men
      Yuni Choi, Jung Eun Lee, Jong-Myon Bae, Zhong-Min Li, Dong-Hyun Kim, Moo-Song Lee, Yoon-Ok Ahn, Myung-Hee Shin
      The Journal of Nutrition.2015; 145(6): 1249.     CrossRef
    • Cytidine Deaminase as a Molecular Predictor of Gemcitabine Response in Patients with Biliary Tract Cancer
      Kyong-Ah Yoon, Sang Myung Woo, Eun Kyung Hong, Mee Kyung Jung, Weon Seo Park, Kieun Bae, Sung-Sik Han, Tae Hyun Kim, Young Hwan Koh, Sang-Jae Park, Woo Jin Lee
      Oncology.2015; 89(6): 345.     CrossRef
    • Pathological upgrading and upstaging of patients eligible for active surveillance according to currently used protocols
      Tae Heon Kim, Hwang Gyun Jeon, Seol Ho Choo, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Han Yong Choi, Hyun Moo Lee
      International Journal of Urology.2014; 21(4): 377.     CrossRef
    • Does Liver Resection Provide Long-Term Survival Benefits for Breast Cancer Patients with Liver Metastasis? A Single Hospital Experience
      Jee Ye Kim, Joon Seong Park, Seung Ah Lee, Jae Keun Kim, Joon Jeong, Dong Sup Yoon, Hy-De Lee
      Yonsei Medical Journal.2014; 55(3): 558.     CrossRef
    • Autoclustering of Non-small Cell Lung Carcinoma Subtypes on 18F-FDG PET Using Texture Analysis: A Preliminary Result
      Seunggyun Ha, Hongyoon Choi, Gi Jeong Cheon, Keon Wook Kang, June-Key Chung, Euishin Edmund Kim, Dong Soo Lee
      Nuclear Medicine and Molecular Imaging.2014; 48(4): 278.     CrossRef
    • Economic Burden of Colorectal Cancer in Korea
      Ju-Young Byun, Seok-Jun Yoon, In-Hwan Oh, Young Ae Kim, Hye-Young Seo, Yo-Han Lee
      Journal of Preventive Medicine & Public Health.2014; 47(2): 84.     CrossRef
    • Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus‐endemic area
      Hee‐Won Kwak, Joong‐Won Park, Byung‐Ho Nam, Ami Yu, Sang Myung Woo, Tae Hyun Kim, Seong Hoon Kim, Young Hwan Koh, Hyun Beom Kim, Sang Jae Park, Woo Jin Lee, Eun Kyung Hong, Chang‐Min Kim
      Journal of Gastroenterology and Hepatology.2014; 29(4): 820.     CrossRef
    • A nomogram predicting the risks of distant metastasis following postoperative radiotherapy for uterine cervical carcinoma: A Korean radiation oncology group study (KROG 12-08)
      Hyoung Uk Je, Seungbong Han, Young Seok Kim, Joo-Hyun Nam, Hak Jae Kim, Jae Weon Kim, Won Park, Duk-Soo Bae, Jin Hee Kim, So Jin Shin, Juree Kim, Ki-Heon Lee, Mee Sun Yoon, Seok Mo Kim, Ji-Yoon Kim, Won Sup Yoon, Nak Woo Lee, Jin Hwa Choi, Sang-Yoon Park,
      Radiotherapy and Oncology.2014; 111(3): 437.     CrossRef
    • Perioperative complication and surgical outcome in patients with spine metastases: Retrospective 200-case series in a single institute
      Byung Ho Lee, Jin-Oh Park, Hak-Sun Kim, Young-Chang Park, Hwan-Mo Lee, Seong-Hwan Moon
      Clinical Neurology and Neurosurgery.2014; 122: 80.     CrossRef
    • An essential microRNA maturing microprocessor complex component DGCR8 is up-regulated in colorectal carcinomas
      Bora Kim, Jae-ho Lee, Jong Wook Park, Taeg Kyu Kwon, Seong Kyu Baek, Ilseon Hwang, Shin Kim
      Clinical and Experimental Medicine.2014; 14(3): 331.     CrossRef
    • Suicide ideation in stomach cancer survivors and possible risk factors
      Ye-Ni Choi, Young-Ae Kim, Young Ho Yun, Sung Kim, Jae-Moon Bae, Young-Woo Kim, Keun Won Ryu, Jun Ho Lee, Jae-Hyung Noh, Tae-Sung Sohn
      Supportive Care in Cancer.2014; 22(2): 331.     CrossRef
    • P2X7Receptor Expression in Coexistence of Papillary Thyroid Carcinoma with Hashimoto's Thyroiditis
      Ji Hyun Kwon, Eun Sook Nam, Hyung Sik Shin, Seong Jin Cho, Hye Rim Park, Mi Jung Kwon
      Korean Journal of Pathology.2014; 48(1): 30.     CrossRef
    • Does Diabetes Mellitus Influence Standardized Uptake Values of Fluorodeoxyglucose Positron Emission Tomography in Colorectal Cancer?
      Da Yeon Oh, Ji Won Kim, Seong-Joon Koh, Mingoo Kim, Ji Hoon Park, Su Yeon Cho, Byeong Gwan Kim, Kook Lae Lee, Jong Pil Im
      Intestinal Research.2014; 12(2): 146.     CrossRef
    • Treatment Outcomes of Transurethral Macroplastique Injection for Postprostatectomy Incontinence
      Sin Woo Lee, Jung Hun Kang, Hyun Hwan Sung, U-Seok Jeong, Young-Suk Lee, Minki Baek, Kyu-Sung Lee
      Korean Journal of Urology.2014; 55(3): 182.     CrossRef
    • Awareness and Ethical Attitudes Toward 'Do-Not-Resuscitate (DNR)' for Cancer Patients
      Joo Yeon Lee, Eun Hee Choi, Kyung Sook Park
      Asian Oncology Nursing.2014; 14(1): 32.     CrossRef
    • Health‐Related Quality of Life After Robot‐Assisted Distal Gastrectomy in Early Gastric Cancer
      Ji Yeon Park, Bang Wool Eom, Min Jung Jo, Hong Man Yoon, Keun Won Ryu, Young‐Woo Kim, Byung‐Ho Nam, Jun Ho Lee
      World Journal of Surgery.2014; 38(5): 1112.     CrossRef
    • Cognitive Deficits in Korean Women Treated With Chemotherapy for Breast Cancer
      Mi Sook Jung, Bernadine Cimprich
      Cancer Nursing.2014; 37(3): E31.     CrossRef
    • EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas
      Dong-Yeop Shin, Im Il Na, Cheol Hyeon Kim, Sunhoo Park, HeeJong Baek, Sung Hyun Yang
      Journal of Thoracic Oncology.2014; 9(2): 195.     CrossRef
    • Long-Term Prognosis of Differentiated Thyroid Cancer with Lung Metastasis in Korea and Its Prognostic Factors
      Sun Wook Cho, Hoon Sung Choi, Gye Jeong Yeom, Jung Ah Lim, Jae Hoon Moon, Do Joon Park, June-Key Chung, Bo Youn Cho, Ka Hee Yi, Young Joo Park
      Thyroid.2014; 24(2): 277.     CrossRef
    • Pre- and intra-operative variables associated with surgical complications in elderly patients with gynecologic cancer: The clinical value of comprehensive geriatric assessment
      Dong Hoon Suh, Jae-Weon Kim, Hee Seung Kim, Hyun Hoon Chung, Noh Hyun Park, Yong Sang Song
      Journal of Geriatric Oncology.2014; 5(3): 315.     CrossRef
    • Meta-analysis of the differentially expressed breast cancer-related microRNA expression profiles
      J. Wu, P. Lu, T. Yang, L. Wang
      Journal of Obstetrics and Gynaecology.2014; 34(7): 630.     CrossRef
    • The study of the coexistence of Hashimoto’s thyroiditis with papillary thyroid carcinoma
      Yun Zhang, Jiaqi Dai, Tingting Wu, Nailin Yang, Zhiqiang Yin
      Journal of Cancer Research and Clinical Oncology.2014; 140(6): 1021.     CrossRef
    • HLA-Cw polypmorphism and killer cell immunoglobulin-like receptor (KIR) gene analysis in Korean colorectal cancer patients
      Hyung-Jin Kim, Hae-Baeg Choi, Jung-Pil Jang, In-Cheol Baek, Eun-Jeong Choi, Miyoung Park, Tai-Gyu Kim, Seong-Taek Oh
      International Journal of Surgery.2014; 12(8): 815.     CrossRef
    • Prognostic impact of diagnosing colorectal neuroendocrine carcinoma using the World Health Organization 2010 classification
      Jong Lyul Lee, Chang Sik Yu, Misung Kim, Seung-Mo Hong, Seok-Byung Lim, Jin Cheon Kim
      Surgery.2014; 155(4): 650.     CrossRef
    • Predictive Value of the Cancer of the Prostate Risk Assessment Score for Recurrence-Free Survival After Radical Prostatectomy in Korea: A Single-Surgeon Series
      Won Ik Seo, Pil Moon Kang, Jae Il Chung
      Korean Journal of Urology.2014; 55(5): 321.     CrossRef
    • Surgical outcomes of robotic thyroid surgery using a double incision gasless transaxillary approach: Analysis of 400 cases treated by the same surgeon
      Yu‐Mi Lee, Onvox Yi, Tae‐Yon Sung, Ki‐Wook Chung, Jong Ho Yoon, Suck Joon Hong
      Head & Neck.2014; 36(10): 1413.     CrossRef
    • Endopelvic fascia preservation during robot-assisted laparoscopic radical prostatectomy: Does it affect urinary incontinence?
      Se Yun Kwon, Jun Nyung Lee, Hyun Tae Kim, Tae-Hwan Kim, Bup Wan Kim, Gyu-Seog Choi, Tae Gyun Kwon
      Scandinavian Journal of Urology.2014; 48(6): 506.     CrossRef
    • Cost-Effectiveness of Liver Cancer Screening in Adults at High Risk for Liver Cancer in the Republic of Korea
      Young Hwa Lee, Kui Son Choi, Jae Kwan Jun, Mina Suh, Hoo-Yeon Lee, Youn Nam Kim, Chung Mo Nam, Eun-Cheol Park, Woo-Hyun Cho
      Cancer Research and Treatment.2014; 46(3): 223.     CrossRef
    • The Role of Palliative Resection for Asymptomatic Primary Tumor in Patients With Unresectable Stage IV Colorectal Cancer
      Jung-A Yun, Jung Wook Huh, Yoon Ah Park, Yong Beom Cho, Seong Hyeon Yun, Hee Cheol Kim, Woo Yong Lee, Ho-Kyung Chun
      Diseases of the Colon & Rectum.2014; 57(9): 1049.     CrossRef
    • Serum 25-hydroxyvitamin D levels correlate with EGFR mutational status in pulmonary adenocarcinoma
      D.-Y. Shin, S. Kim, S. Park, J. S. Koh, C. H. Kim, H. Baek, S. H. Yang, I. I. Na
      Endocrine Related Cancer.2014; 21(5): 715.     CrossRef
    • Effectiveness and safety of cabazitaxel plus prednisolone chemotherapy for metastatic castration-resistant prostatic carcinoma: data on Korean patients obtained by the cabazitaxel compassionate-use program
      Jae-Lyun Lee, Se Hoon Park, Su-Jin Koh, Se Hoon Lee, Yu Jung Kim, Yoon Ji Choi, Jihye Lee, Ho Yeong Lim
      Cancer Chemotherapy and Pharmacology.2014; 74(5): 1005.     CrossRef
    • Simvastatin plus capecitabine–cisplatin versus placebo plus capecitabine–cisplatin in patients with previously untreated advanced gastric cancer: A double-blind randomised phase 3 study
      Seung Tae Kim, Jung Hun Kang, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, In Gyu Hwang, Sang-Cheol Lee, Keon-Woo Park, Hyo Rak Lee, Won Ki Kang
      European Journal of Cancer.2014; 50(16): 2822.     CrossRef
    • Usefulness of Urine Cytology as a Routine Work-up in the Detection of Recurrence in Patients With Prior Non-Muscle-Invasive Bladder Cancer: Practicality and Cost-Effectiveness
      Bong Gi Ok, Yoon Seob Ji, Young Hwii Ko, Phil Hyun Song
      Korean Journal of Urology.2014; 55(10): 650.     CrossRef
    • Increase of diesel car raises health risk in spite of recent development in engine technology
      Jong Han Leem, Young-Kee Jang
      Environmental Health and Toxicology.2014; 29: e2014009.     CrossRef
    • Dermatomyositis Associated with Gallbladder Cancer
      Jin Su Park, Jung Yoon Pyo, Yong-Beom Park, Soo-Kon Lee, Sang-Won Lee
      Journal of Rheumatic Diseases.2014; 21(5): 261.     CrossRef
    • Computed Tomography Features of Papillary Thyroid Carcinomas
      Dong Wook Kim
      Journal of Computer Assisted Tomography.2014; 38(6): 936.     CrossRef
    • Coexistence of Histologically Confirmed Hashimoto’s Thyroiditis with Different Stages of Papillary Thyroid Carcinoma in a Consecutive Chinese Cohort
      Xiaoyun Liu, Lijun Zhu, Dai Cui, Zhixiao Wang, Huanhuan Chen, Yu Duan, Meiping Shen, Yunsong Wu, Rong Rong, Zhihong Zhang, Xiaodong Wang, Jiawei Chen, Erik K. Alexander, Tao Yang
      International Journal of Endocrinology.2014; 2014: 1.     CrossRef
    • Factors Associated with Organized and Opportunistic Cancer Screening: Results of the Korea National Health and Nutrition Examination Survey (KNHANES) 2007-2011
      Minsun Kang, Ki-Bong Yoo, Eun-Cheol Park, Kisung Kwon, Gaeun Kim, Doo Ree Kim, Jeoung A Kwon
      Asian Pacific Journal of Cancer Prevention.2014; 15(7): 3279.     CrossRef
    • Environmental Radioactivity and High Incidence Rates of Stomach and Esophagus Cancer in the Van Lake Region: A Causal Relationship?
      Zafer Akan, Busranur Baskurt, Hizir Asliyuksek, Erol Kam, Ahmet Yilmaz, Mehmet Bilgehan Yuksel, Recep Biyik, Ramazan Esen, Dogan Koca
      Asian Pacific Journal of Cancer Prevention.2014; 15(1): 375.     CrossRef
    • Visualization and interpretation of cancer data using linked micromap plots
      Se Jin Park, Jeong Yong Ahn
      Journal of the Korean Data and Information Science Society.2014; 25(6): 1531.     CrossRef
    • Microsatellite Instability of Nuclear and Mitochondrial DNAs in Gastric Carcinogenesis
      Jae-Ho Lee, Dae-Kwang Kim
      Asian Pacific Journal of Cancer Prevention.2014; 15(19): 8027.     CrossRef
    • Attributable fraction of tobacco smoking on cancer using population-based nationwide cancer incidence and mortality data in Korea
      Sohee Park, Sun Ha Jee, Hai-Rim Shin, Eun Hye Park, Aesun Shin, Kyu-Won Jung, Seung-Sik Hwang, Eun Shil Cha, Young Ho Yun, Sue Kyung Park, Mathieu Boniol, Paolo Boffetta
      BMC Cancer.2014;[Epub]     CrossRef
    • Population-Attributable Causes of Cancer in Korea: Obesity and Physical Inactivity
      Sohee Park, Yeonju Kim, Hai-Rim Shin, Boram Lee, Aesun Shin, Kyu-Won Jung, Sun Ha Jee, Dong Hyun Kim, Young Ho Yun, Sue Kyung Park, Mathieu Boniol, Paolo Boffetta, Yiqing Song
      PLoS ONE.2014; 9(4): e90871.     CrossRef
    • Risk Prediction Model for Colorectal Cancer: National Health Insurance Corporation Study, Korea
      Aesun Shin, Jungnam Joo, Hye-Ryung Yang, Jeongin Bak, Yunjin Park, Jeongseon Kim, Jae Hwan Oh, Byung-Ho Nam, Zhengdong Zhang
      PLoS ONE.2014; 9(2): e88079.     CrossRef
    • Apigenin-induced apoptosis is enhanced by inhibition of autophagy formation in HCT116 human colon cancer cells
      YUJIN LEE, BOKYUNG SUNG, YONG JUNG KANG, DONG HWAN KIM, JUNG-YOON JANG, SEONG YEON HWANG, MINJUNG KIM, HYUN SOOK LIM, JEONG-HYUN YOON, HAE YOUNG CHUNG, NAM DEUK KIM
      International Journal of Oncology.2014; 44(5): 1599.     CrossRef
    • Arsenic hexoxide enhances TNF-α-induced anticancer effects by inhibiting NF-κB activity at a safe dose in MCF-7 human breast cancer cells
      MIN JEONG KIM, JI HYUN JUNG, WON SUP LEE, JEONG WON YUN, JING NAN LU, SANG MI YI, HYE JUNG KIM, SEONG-HWAN CHANG, GON-SUP KIM, SOON CHAN HONG, WOO SONG HA
      Oncology Reports.2014; 31(5): 2305.     CrossRef
    • Sudden hearing loss due to internal auditory canal metastasis of Her2-positive gastric cancer: A case report
      CHANG-HEE KIM, JUNG EUN SHIN, HONG GEE ROH, JONG SIK LEE, SO YOUNG YOON
      Oncology Letters.2014; 8(1): 394.     CrossRef
    • Silibinin Induces Cell Death through Reactive Oxygen Species–Dependent Downregulation of Notch-1/ERK/Akt Signaling in Human Breast Cancer Cells
      Thae Hyun Kim, Jae Suk Woo, Yong Keun Kim, Ki Hyung Kim
      Journal of Pharmacology and Experimental Therapeutics.2014; 349(2): 268.     CrossRef
    • NVP-BEZ-235 enhances radiosensitization via blockade of the PI3K/mTOR pathway in cisplatin-resistant non-small cell lung carcinoma.
      Kwang Woon Kim, Carey J. Myers, Dae Kwang Jung, Bo Lu
      Genes & Cancer.2014; 5(7-8): 293.     CrossRef
    • The Prevalence of Colorectal Adenomas in Asymptomatic Korean Men and Women
      Moon Hee Yang, Sanjay Rampal, Jidong Sung, Yoon-Ho Choi, Hee Jung Son, Jun Haeng Lee, Young-Ho Kim, Dong Kyung Chang, Poong-Lyul Rhee, Jong Chul Rhee, Eliseo Guallar, Juhee Cho
      Cancer Epidemiology, Biomarkers & Prevention.2014; 23(3): 499.     CrossRef
    • Radiotherapeutic Options for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
      Dong Soo Lee, Jinsil Seong
      Liver Cancer.2014; 3(1): 18.     CrossRef
    • Loss of E-Cadherin Expression Is Associated with a Poor Prognosis in Stage III Colorectal Cancer
      Jung-A Yun, Seok-Hyung Kim, Hye Kyung Hong, Seong Hyeon Yun, Hee Cheol Kim, Ho-Kyung Chun, Yong Beom Cho, Woo Yong Lee
      Oncology.2014; 86(5-6): 318.     CrossRef
    • Clinical significance of incidental thyroid nodules identified on low-dose CT for lung cancer screening
      Jong Lee, Sun Jeong, Yee Kim
      Multidisciplinary Respiratory Medicine.2013; 8(1): 56.     CrossRef
    • Data on the Characteristics and the Survival of Korean Patients With Colorectal Cancer From the Korea Central Cancer Registry
      Hyoung-Chul Park, Aesun Shin, Byung-Woo Kim, Kyu-Won Jung, Young-Joo Won, Jae Hwan Oh, Seung-Yong Jeong, Chang Sik Yu, Bong Hwa Lee
      Annals of Coloproctology.2013; 29(4): 144.     CrossRef
    • The Establishment of K-CaP (the Multicenter Korean Prostate Cancer Database)
      Dong Hoon Lee, Seung Hwan Lee, Koon Ho Rha, In Young Choi, Ji Youl Lee, Sae Woong Kim, Sangchul Lee, Sung Kyu Hong, Seok-Soo Byun, In Gab Jeong, Jun Hyuk Hong, Choung-Soo Kim, Hwang Gyun Jeon, Hyun Moo Lee, Byung Ha Chung
      Korean Journal of Urology.2013; 54(4): 229.     CrossRef
    • Do Positive Surgical Margins Predict Biochemical Recurrence in All Patients Without Adjuvant Therapy After Radical Prostatectomy?
      Jun Woo Lee, Jae Hyun Ryu, Yun Beom Kim, Seung Ok Yang, Jeong Kee Lee, Tae Young Jung
      Korean Journal of Urology.2013; 54(8): 510.     CrossRef
    • Comparison between preoperative and postoperative concurrent chemoradiotherapy for rectal cancer: an institutional analysis
      Jeong Won Lee, Jong Hoon Lee, Jun-Gi Kim, Seong Taek Oh, Hyuk Jun Chung, Myung Ah Lee, Hoo Geun Chun, Song Mi Jeong, Sei Chul Yoon, Hong Seok Jang
      Radiation Oncology Journal.2013; 31(3): 155.     CrossRef
    • Lung Cancer Incidence by Smoking Status in Korean Men: 16-Years of Observations in the Seoul Male Cancer Cohort Study
      Jong-Myon Bae, Zhong-Min Li, Myung-Hee Shin, Dong-Hyun Kim, Moo-Song Lee, Yoon-Ok Ahn
      Journal of Korean Medical Science.2013; 28(4): 636.     CrossRef
    • Recent Trends (1991-2010) of Metastatic Skin Cancers in Korea
      Chul Hwan Bang, Jung Min Bae, Hei Sung Kim, Gyeong Mun Kim, Dong Soo Yu, Hyun Jeong Park, Shin Tack Oh, Hoon Kang, Chul Jong Park, Jeong Deuk Lee, Jun Young Lee, Hyung Ok Kim, Young Min Park
      Journal of Korean Medical Science.2013; 28(7): 1083.     CrossRef
    • Determinants of suboptimal hepatitis B vaccine uptake among men in the Republic of Korea: where should our efforts be focused: results from cross-sectional study
      Boyoung Park, Kui Son Choi, Hoo-Yeon Lee, Min-Son Kwak, Jae Kwan Jun, Eun-Cheol Park
      BMC Infectious Diseases.2013;[Epub]     CrossRef
    • Fasting Blood Sugar and Serum Triglyceride as the Risk Factors of Colorectal Adenoma in Korean Population Receiving Screening Colonoscopy
      Jeung Hui Pyo, Eun Sun Kim, Hoon Jai Chun, Bora Keum, Yoon Tae Jeen, Hong Sik Lee, Chang Duck Kim, Ho Sang Ryu, Young Ha Kim, Jung Eun Lee
      Clinical Nutrition Research.2013; 2(1): 34.     CrossRef
    • S-1 plus irinotecan and oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: a prospective phase II study and pharmacogenetic analysis
      S Y Kim, Y S Hong, E K Shim, S-Y Kong, A Shin, J Y Baek, K H Jung
      British Journal of Cancer.2013; 109(6): 1420.     CrossRef
    • A propensity score–matched case–control comparative study of laparoscopic and open extended (D2) lymph node dissection for distal gastric carcinoma
      Xue-Feng Zhao, Oh Jeong, Mi Ran Jung, Seong Yeop Ryu, Young Kyu Park
      Surgical Endoscopy.2013; 27(8): 2792.     CrossRef
    • Changes in the Clinicopathological Characteristics and Outcomes of Thyroid Cancer in Korea over the Past Four Decades
      Bo Youn Cho, Hoon Sung Choi, Young Joo Park, Jung Ah Lim, Hwa Young Ahn, Eun Kyung Lee, Kyung Won Kim, Ka Hee Yi, June-Key Chung, Yeo-Kyu Youn, Nam Han Cho, Do Joon Park, Chang-Soon Koh
      Thyroid.2013; 23(7): 797.     CrossRef
    • Indications for Fine Needle Aspiration in Thyroid Nodules
      Jin Young Kwak
      Endocrinology and Metabolism.2013; 28(2): 81.     CrossRef
    • Hypofractionated radiotherapy with Tomotherapy for patients with hepatic oligometastases: retrospective analysis of two institutions
      Jong Hoon Lee, Joo Hwan Lee, Hong Seok Jang, Hyo Chun Lee, Jung Won Lee, Dae Gyu Kang, Byoung Yong Shim, Bong-Hyeon Kye, Hyung Jin Kim, Hyeon-Min Cho, Young Jin Suh, Sung Hwan Kim
      Clinical & Experimental Metastasis.2013; 30(5): 643.     CrossRef
    • Early Colorectal Epithelial Neoplasm in Korea: A Multicenter Survey of Pathologic Diagnosis
      Yun Kyung Kang, So-Young Jin, Mee Soo Chang, Jung Yeon Kim, Gyeong Hoon Kang, Hye Seung Lee, Jin Hee Sohn, Ho Sung Park, Kye Won Kwon, Mi Jin Gu, Young Hee Maeng, Jong Eun Joo, Haeng Ji Kang, Hee Kyung Kim, Kee-Taek Jang, Mi Ja Lee, Hee Kyung Chang, Joon
      Korean Journal of Pathology.2013; 47(3): 245.     CrossRef
    • Thyroid Cancer is the Most Common Cancer in Women, Based on the Data from Population-based Cancer Registries, South Korea
      S.-S. Kweon, M.-H. Shin, I.-J. Chung, Y.-J. Kim, J.-S. Choi
      Japanese Journal of Clinical Oncology.2013; 43(10): 1039.     CrossRef
    • Time Trend of Out-of-pocket Expenditure among Cancer Inpatients: Evidence from Korean Tertiary Hospitals
      Chang Hoon You, Sungwook Kang, Young Dae Kwon, Ji Heon Choi
      Asian Pacific Journal of Cancer Prevention.2013; 14(11): 6985.     CrossRef
    • Hospitalization Decreases Serum Prostate-Specific Antigen Values Compared With Outpatient Values in Patients With Benign Prostatic Diseases
      In Seok Yoon, Tae Young Shin, Sun Il Kim, Seong Kon Park, Hyun Ik Jang, Jong Bo Choi, Hyun Soo Ahn, Young Soo Kim, Se Joong Kim
      Korean Journal of Urology.2013; 54(9): 593.     CrossRef
    • Guidelines for the Diagnosis and Treatment ofHelicobacter pyloriInfection in Korea, 2013 Revised Edition
      Sang Gyun Kim, Hye-Kyung Jung, Hang Lak Lee, Jae Young Jang, Hyuk Lee, Chan Gyoo Kim, Woon Geon Shin, Ein Soon Shin, Yong Chan Lee
      The Korean Journal of Gastroenterology.2013; 62(1): 3.     CrossRef
    • Comparison of short-term outcomes after elective surgery following endoscopic stent insertion and emergency surgery for obstructive colorectal cancer
      Gil Jae Lee, Hyo Jun Kim, Jeong-Heum Baek, Won-Suk Lee, Kwang An Kwon
      International Journal of Surgery.2013; 11(6): 442.     CrossRef
    • Korean Prostate Cancer Patients Have Worse Disease Characteristics than their American Counterparts
      Dong Il Kang, Jae Il Chung, Hong Koo Ha, Kweonsik Min, Jangho Yoon, Wansuk Kim, Won Ik Seo, Pil Moon Kang, Soo Jin Jung, Isaac Yi Kim
      Asian Pacific Journal of Cancer Prevention.2013; 14(11): 6913.     CrossRef
    • Cell-Free microRNA-214 From Urine as a Biomarker for Non-Muscle-Invasive Bladder Cancer
      Sung Min Kim, Ho Won Kang, Won Tae Kim, Yong-June Kim, Seok Joong Yun, Sang-Cheol Lee, Wun-Jae Kim
      Korean Journal of Urology.2013; 54(11): 791.     CrossRef
    • Antiadhesive effect and safety of sodium hyaluronate-carboxymethyl cellulose membrane in thyroid surgery
      Dong Sik Bae, Jung-Woo Woo, Se Hyun Paek, Hyungju Kwon, Young Jun Chai, Su-jin Kim, June Young Choi, Kyu Eun Lee, Yeo-Kyu Youn
      Journal of the Korean Surgical Society.2013; 85(5): 199.     CrossRef
    • Patterns of physical activity participation across the cancer trajectory in colorectal cancer survivors
      Jae Youn Chung, Dong Hoon Lee, Ji-Hye Park, Mi Kyung Lee, Dong-Woo Kang, Jihee Min, Dong-Il Kim, Duck Hyoun Jeong, Nam Kyu Kim, Jeffrey A. Meyerhardt, Lee W. Jones, Justin Y. Jeon
      Supportive Care in Cancer.2013; 21(6): 1605.     CrossRef
    • Prevalence of human papillomavirus infection and genotype distribution determined by the cyclic-catcher melting temperature analysis in Korean medical checkup population
      Yun-Jee Kim, Min-Jung Kwon, Hee-Yeon Woo, Soon-Young Paik
      Journal of Microbiology.2013; 51(5): 665.     CrossRef
    • Clinical Significance of Preoperative Inflammatory Parameters in Gastric Cancer Patients
      Deuk Young Lee, Seong Woo Hong, Yeo Goo Chang, Woo Yong Lee, Byungmo Lee
      Journal of Gastric Cancer.2013; 13(2): 111.     CrossRef
    • Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients
      Sang-Jeon Lee, Song Yi Choi, Wun-Jae Kim, Meiying Ji, Taek-Gu Lee, Bo-Ra Son, Soon Man Yoon, Rohyun Sung, Eun Jeoung Lee, Sei Jin Youn, Seon Mee Park
      Diagnostic Pathology.2013;[Epub]     CrossRef
    • Advances in management of thyroid cancer
      Judy Jin, Roy Phitayakorn, Scott M. Wilhelm, Christopher R. McHenry
      Current Problems in Surgery.2013; 50(6): 241.     CrossRef
    • Individualized Prediction of Overall Survival After Postoperative Radiation Therapy in Patients With Early-Stage Cervical Cancer: A Korean Radiation Oncology Group Study (KROG 13-03)
      Hyun Jin Lee, Seungbong Han, Young Seok Kim, Joo-Hyun Nam, Hak Jae Kim, Jae Weon Kim, Won Park, Byoung-Gie Kim, Jin Hee Kim, Soon Do Cha, Juree Kim, Ki-Heon Lee, Mee Sun Yoon, Seok Mo Kim, Ji-Yoon Kim, Won Sup Yoon, Nak Woo Lee, Jin Hwa Choi, Sang-Yoon Pa
      International Journal of Radiation Oncology*Biology*Physics.2013; 87(4): 659.     CrossRef
    • Recent trends in hepatitis B virus infection in the general Korean population
      Hyuck Kim, A Ri Shin, Hoe Hoon Chung, Min Kyoung Kim, Ji Sung Lee, Jae-Jun Shim, Byung-Ho Kim
      The Korean Journal of Internal Medicine.2013; 28(4): 413.     CrossRef
    • A missense polymorphism (rs11466653, Met326Thr) of toll-like receptor 10 (TLR10) is associated with tumor size of papillary thyroid carcinoma in the Korean population
      Su Kang Kim, Hae Jeong Park, Il Ki Hong, Joo-Ho Chung, Young Gyu Eun
      Endocrine.2013; 43(1): 161.     CrossRef
    • Role of adjuvant postoperative external beam radiotherapy for well differentiated thyroid cancer
      Jeanny Kwon, Hong-Gyun Wu, Yeo-Kyu Youn, Kyu Eun Lee, Kwang Hyun Kim, Do Joon Park
      Radiation Oncology Journal.2013; 31(3): 162.     CrossRef
    • Health Care Utilization in Women with Cervical Cancer and Cervical Intraepithelial Neoplasia
      Hee Sun Kang, Hanju Lee
      Asian Oncology Nursing.2013; 13(1): 37.     CrossRef
    • Preoperative Plasma Hyperfibrinogenemia is Predictive of Poor Prognosis in Patients with Nonmetastatic Colon Cancer
      Hae-Jung Son, Ji Won Park, Hee Jin Chang, Dae Yong Kim, Byung Chang Kim, Sun Young Kim, Sung Chan Park, Hyo Seong Choi, Jae Hwan Oh
      Annals of Surgical Oncology.2013; 20(9): 2908.     CrossRef
    • Effects of a 12-week home-based exercise program on the level of physical activity, insulin, and cytokines in colorectal cancer survivors: a pilot study
      Dong Hoon Lee, Ji Young Kim, Mi Kyung Lee, Choae Lee, Ji-Hee Min, Duck Hyoun Jeong, Ji-Won Lee, Sang Hui Chu, Jeffrey A. Meyerhardt, Jennifer Ligibel, Lee W. Jones, Nam Kyu Kim, Justin Y. Jeon
      Supportive Care in Cancer.2013; 21(9): 2537.     CrossRef
    • Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients
      Su Jin Lee, Jongtae Lee, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Kyoung-Mee Kim, In-Gu Do, Sin-Ho Jung, Dong-Seok Yim, Won Ki Kang
      Investigational New Drugs.2013; 31(6): 1580.     CrossRef
    • Chemotherapy for Advanced Gastric Cancer: Review and Update of Current Practices
      Sung Chul Park, Hoon Jai Chun
      Gut and Liver.2013; 7(4): 385.     CrossRef
    • The Korean Hereditary Breast Cancer Study: Review and Future Perspectives
      Eunyoung Kang, Sung-Won Kim
      Journal of Breast Cancer.2013; 16(3): 245.     CrossRef
    • Prediction of Cancer Incidence and Mortality in Korea, 2013
      Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Chang-Mo Oh, Hong Gwan Seo, Jin-Soo Lee
      Cancer Research and Treatment.2013; 45(1): 15.     CrossRef
    • Trends of human papillomavirus‐related head and neck cancers in Korea: National cancer registry data
      Aesun Shin, Yuh‐S. Jung, Kyu‐Won Jung, Kyeezu Kim, Junsun Ryu, Young‐Joo Won
      The Laryngoscope.2013;[Epub]     CrossRef
    • Erythrocyte sedimentation rate and anaemia are independent predictors of survival in patients with clear cell renal cell carcinoma
      Y Choi, B Park, K Kim, B C Jeong, S I Seo, S S Jeon, H Y Choi, J E Lee, H M Lee
      British Journal of Cancer.2013; 108(2): 387.     CrossRef
    • Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancer
      J.S. Lee, S. Park, J.M. Park, J.H. Cho, S.I. Kim, B.-W. Park
      Annals of Oncology.2013; 24(5): 1225.     CrossRef
    • Impact of local surgical treatment on survival in young women with T1 breast cancer: long-term results of a population-based cohort
      Ye Won Jeon, Jung Eun Choi, Heung Kyu Park, Ku Sang Kim, Jee Yeon Lee, Young Jin Suh
      Breast Cancer Research and Treatment.2013; 138(2): 475.     CrossRef
    • Association of Human Epidermal Growth Factor Receptor 2 with Radiotherapy Resistance in Patients with T1N0M0 Breast Cancer
      Hyun-Ah Kim, Eun-Kyu Kim, Min-Soo Kim, Jong-Han Yu, Mi-Ri Lee, Hae Kyung Lee, Young-Jin Suh, Woo Chul Noh
      Journal of Breast Cancer.2013; 16(3): 266.     CrossRef
    • Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010
      Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Chang-Mo Oh, Hong Gwan Seo, Jin-Soo Lee
      Cancer Research and Treatment.2013; 45(1): 1.     CrossRef
    • The changing face of thyroid cancer in a population‐based cohort
      K. Alok Pathak, William D. Leslie, Thomas C. Klonisch, Richard W. Nason
      Cancer Medicine.2013; 2(4): 537.     CrossRef
    • Clinical Prognostic Factors for Locally Advanced Esophageal Squamous Carcinoma Treated after Definitive Chemoradiotherapy
      Dae-Eun Kim, Uh-Jin Kim, Won-Young Choi, Mi-Young Kim, Seung-Hun Kim, Min-Jee Kim, Hyun-Jeong Shim, Jun-Eul Hwang, Woo-Kyun Bae, Ik-Joo Chung, Taek-Keun Nam, Kook-Joo Na, Sang-Hee Cho
      Cancer Research and Treatment.2013; 45(4): 276.     CrossRef
    • The Korean Version of the Body Image Scale-Reliability and Validity in a Sample of Breast Cancer Patients
      Dongwoo Khang, Hyo-Deog Rim, Jungmin Woo
      Psychiatry Investigation.2013; 10(1): 26.     CrossRef
    • Preoperative elevation of carcinoembryonic antigen predicts poor tumor response and frequent distant recurrence for patients with rectal cancer who receive preoperative chemoradiotherapy and total mesorectal excision: a multi-institutional analysis in an
      Jong Hoon Lee, Sung Hwan Kim, Hong Seok Jang, Hyuk Jun Chung, Seong Taek Oh, Doo Seok Lee, Jun-Gi Kim
      International Journal of Colorectal Disease.2013; 28(4): 511.     CrossRef
    • Knockdown of cysteine-rich 61 inhibits proliferation, migration, and invasiveness of prostate carcinoma PC-3 cells
      Yoon-Jin Lee, David M. Lee, Dong-Jun Jeong, Jung-Hyun Shim, Chang-Ho Lee, Young-Jin Choi, Hae-Seon Nam, Moon-Kyun Cho, Sang-Han Lee
      Animal Cells and Systems.2013; 17(5): 306.     CrossRef
    • Effects of a Smartphone Application on Breast Self-Examination: A Feasibility Study
      Jaesung Heo, Mison Chun, Ki Young Lee, Young-Taek Oh, O Kyu Noh, Rae Woong Park
      Healthcare Informatics Research.2013; 19(4): 250.     CrossRef
    • The Role of Surgery for Asymptomatic Primary Tumors in Unresectable Stage IV Colorectal Cancer
      Young Wan Kim, Ik Yong Kim
      Annals of Coloproctology.2013; 29(2): 44.     CrossRef
    • Sociodemographic Characteristics of Underweight Korean Adults: Korea National Health and Nutrition Examination Survey, 2007-2010
      Sung Il Park, Young Gyu Cho, Jae Heon Kang, Hyun Ah Park, Kyoung Woo Kim, Yang Im Hur, Hye Jin Kang
      Korean Journal of Family Medicine.2013; 34(6): 385.     CrossRef
    • Validity and Reliability of the Korean Version of the MD Anderson Dysphagia Inventory for Head and Neck Cancer Patients
      Chan-Hyuk Kwon, Yeo Hyung Kim, Jae Hyeon Park, Byung-Mo Oh, Tai Ryoon Han
      Annals of Rehabilitation Medicine.2013; 37(4): 479.     CrossRef
    • Is esophagogastroduodenoscopy necessary in patients with positive fecal occult blood tests and negative colonoscopy?
      Ja Sung Choi, Jin Yi Choi, Hyeon Geun Cho, Ki Jun Han, Hee Man Kim, Jae Hee Cho, Yu Jin Kim
      Scandinavian Journal of Gastroenterology.2013; 48(6): 657.     CrossRef
    • Prevalence and predictors of anxiety and depression among family caregivers of cancer patients: a nationwide survey of patient–family caregiver dyads in Korea
      Boyoung Park, So Young Kim, Ji-Yeon Shin, Robert W. Sanson-Fisher, Dong Wook Shin, Juhee Cho, Jong-Hyock Park
      Supportive Care in Cancer.2013; 21(10): 2799.     CrossRef
    • Trends in Cancer Screening Rates among Korean Men and Women: Results from the Korean National Cancer Screening Survey, 2004-2012
      Mina Suh, Kui Son Choi, Yoon Young Lee, Jae Kwan Jun
      Cancer Research and Treatment.2013; 45(2): 86.     CrossRef
    • Role of salvage radiotherapy for regional lymph node recurrence after radical surgery in advanced gastric cancer
      Byoung Hyuck Kim, Keun-Yong Eom, Jae-Sung Kim, Hyung-Ho Kim, Do Joong Park
      Radiation Oncology Journal.2013; 31(3): 147.     CrossRef
    • Heterogeneous echogenicity of the underlying thyroid parenchyma: how does this affect the analysis of a thyroid nodule?
      Mina Park, So Hee Park, Eun-Kyung Kim, Jung Hyun Yoon, Hee Jung Moon, Hye Sun Lee, Jin Young Kwak
      BMC Cancer.2013;[Epub]     CrossRef
    • Quercetin Regulates Sestrin 2-AMPK-mTOR Signaling Pathway and Induces Apoptosis via Increased Intracellular ROS in HCT116 Colon Cancer Cells
      Guen Tae Kim, Se Hee Lee, Young Min Kim
      Journal of Cancer Prevention.2013; 18(3): 264.     CrossRef
    • Trends in the Incidence of In Situ and Invasive Cervical Cancer by Age Group and Histological Type in Korea from 1993 to 2009
      Chang-Mo Oh, Kyu-Won Jung, Young-Joo Won, Aesun Shin, Hyun-Joo Kong, Jae Kwan Jun, Sang-yoon Park, Wael El-Rifai
      PLoS ONE.2013; 8(8): e72012.     CrossRef
    • Individualized Risk Prediction Model for Lung Cancer in Korean Men
      Sohee Park, Byung-Ho Nam, Hye-Ryung Yang, Ji An Lee, Hyunsun Lim, Jun Tae Han, Il Su Park, Hai-Rim Shin, Jin Soo Lee, Olga Y. Gorlova
      PLoS ONE.2013; 8(2): e54823.     CrossRef
    • Validity of Fecal Occult Blood Test in the National Cancer Screening Program, Korea
      Aesun Shin, Kui Son Choi, Jae Kwan Jun, Dai Keun Noh, Mina Suh, Kyu-Won Jung, Byung Chang Kim, Jae Hwan Oh, Eun-Cheol Park, John Souglakos
      PLoS ONE.2013; 8(11): e79292.     CrossRef
    • Factors Associated with Compliance with Recommendations for Liver Cancer Screening in Korea: A Nationwide Survey in Korea
      Boyoung Park, Kui Son Choi, Mina Suh, Ji-Yeon Shin, Jae Kwan Jun, Hiromu Suzuki
      PLoS ONE.2013; 8(6): e68315.     CrossRef
    • Hashimoto’s Thyroiditis as a Risk Factor of Papillary Thyroid Cancer May Improve Cancer Prognosis
      Yu Lun, Xiaoyu Wu, Qian Xia, Yanshuo Han, Xiaoyu Zhang, Zhimin Liu, Fengyi Wang, Zhiquan Duan, Shijie Xin, Jian Zhang
      Otolaryngology–Head and Neck Surgery.2013; 148(3): 396.     CrossRef
    • Korean Risk Assessment Model for Breast Cancer Risk Prediction
      Boyoung Park, Seung Hyun Ma, Aesun Shin, Myung-Chul Chang, Ji-Yeob Choi, Sungwan Kim, Wonshik Han, Dong-Young Noh, Sei-Hyun Ahn, Daehee Kang, Keun-Young Yoo, Sue K. Park, Todd W. Miller
      PLoS ONE.2013; 8(10): e76736.     CrossRef
    • Prognostic significance of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in biliary tract cancer patients receiving adjuvant 5-fluorouracil-based chemotherapy
      KWAN WOO KIM, HYUK-CHAN KWON, SUNG-HYUN KIM, SUNG YONG OH, SUEE LEE, JI HYUN LEE, MYUNG HWAN ROH, MIN CHAN KIM, KI HAN KIM, YOUNG HOON KIM, YOUNG HOON ROH, JIN SOOK JEONG, HYO-JIN KIM
      Molecular and Clinical Oncology.2013; 1(6): 987.     CrossRef
    • Leukemia cutis in a patient with acute monocytic leukemia diagnosed simultaneously with hepatocellular carcinoma: A case study
      DONG KEUN SEOK, SAE YOON KEE, SOON YOUNG KO, JUNG HWA LEE, HYE YOUNG KIM, IN SUN KIM, HEE YEON SEO
      Oncology Letters.2013; 6(5): 1319.     CrossRef
    • Association of Smoking History with Cancer Recurrence and Survival in Stage III–IV Male Gastric Cancer Patients
      Mi Ah Han, Young-Woo Kim, Il Ju Choi, Myueng Guen Oh, Chan Gyoo Kim, Jong Yeul Lee, Soo-Jeong Cho, Bang Wool Eom, Hong Man Yoon, Keun Won Ryu
      Cancer Epidemiology, Biomarkers & Prevention.2013; 22(10): 1805.     CrossRef
    • Gemcitabine plus Cisplatin versus Capecitabine plus Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer: A Retrospective Cohort Study
      Sang Myung Woo, Woo Jin Lee, Ji Hun Kim, Dong Hwan Kim, Sung-Sik Han, Sang-Jae Park, Tae Hyun Kim, Ju Hee Lee, Young Hwan Koh, Eun Kyung Hong
      Chemotherapy.2013; 59(3): 232.     CrossRef
    • Cross-Cultural Application of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Prostate Cancer - EORTC QLQ-PR25
      Jinsung Park, Dong Wook Shin, Seok Joong Yun, Sung-Woo Park, Seong Soo Jeon, Cheol Kwak, Tae Gyun Kwon, Hyung Jin Kim, Hanjong Ahn
      Oncology.2013; 85(5): 299.     CrossRef
    • Changes in Prostate Cancer Aggressiveness over a 12-Year Period in Korea
      Doejung Kim, Daeheon Choi, Ju Hyun Lim, Jong Hyun Yoon, In Gab Jeong, Dalsan You, Jun Hyuk Hong, Hanjong Ahn, Choung-Soo Kim
      Korean Journal of Urology.2012; 53(10): 680.     CrossRef
    • The role of postoperative pelvic radiation in stage IV rectal cancer after resection of primary tumor
      Joo Hwan Lee, In Young Jo, Jong Hoon Lee, Sei Chul Yoon, Yeon-Sil Kim, Byung Ock Choi, Jun-Gi Kim, Seong Taek Oh, Myeong A Lee, Hong-Seok Jang
      Radiation Oncology Journal.2012; 30(4): 205.     CrossRef
    • Expression of Placenta Growth Factor in Colorectal Carcinomas
      Chan Yong Sung, Myoung Won Son, Tae Sung Ahn, Dong Jun Jung, Moon Soo Lee, Moo Jun Baek
      Journal of the Korean Society of Coloproctology.2012; 28(6): 315.     CrossRef
    • Costs During the First Five Years Following Cancer Diagnosis in Korea
      Ji-Yeon Shin, So Young Kim, Kun-Sei Lee, Sang-Il Lee, Young Ko, Young-Soon Choi, Hong Gwan Seo, Joo-Hyuk Lee, Jong-Hyock Park
      Asian Pacific Journal of Cancer Prevention.2012; 13(8): 3767.     CrossRef
    • FAM70Bas a Novel Prognostic Marker for Cancer Progression and Cancer-Specific Death in Muscle-Invasive Bladder Cancer
      Ho-Won Kang, Hyung-Yoon Yoon, Yun-Sok Ha, Won Tae Kim, Yong-June Kim, Seok-Joong Yun, Sang-Cheol Lee, Wun-Jae Kim
      Korean Journal of Urology.2012; 53(9): 598.     CrossRef
    • Reply to the letter to the editor on hepatitis B virus infection adds lymphoma burden in Korea
      Aesun Shin, Hai-Rim Shin
      Annals of Oncology.2012; 23(7): 1926.     CrossRef
    • Factors Associated with the Use of Gastric Cancer Screening Services in Korea: The Fourth Korea National Health and Nutrition Examination Survey 2008 (KNHANES IV)
      Ji-Yeon Shin, Duk-Hee Lee
      Asian Pacific Journal of Cancer Prevention.2012; 13(8): 3773.     CrossRef
    • Association Study between Folate Pathway Gene Single Nucleotide Polymorphisms and Gastric Cancer in Koreans
      Jae-Young Yoo, Sook-Young Kim, Jung-Ah Hwang, Seung-Hyun Hong, Aesun Shin, Il Ju Choi, Yeon-Su Lee
      Genomics & Informatics.2012; 10(3): 184.     CrossRef
    • The diagnosis of healthcare policy problems in Korea
      Eun-Cheol Park, Sung-In Jang
      Journal of the Korean Medical Association.2012; 55(10): 932.     CrossRef
    • Increasing Trend of Colorectal Cancer Incidence in Korea, 1999-2009
      Aesun Shin, Kyee-Zu Kim, Kyu-Won Jung, Sohee Park, Young-Joo Won, Jeongseon Kim, Dae Yong Kim, Jae Hwan Oh
      Cancer Research and Treatment.2012; 44(4): 219.     CrossRef
    • Comparison of Pathological Outcomes of Active Surveillance Candidates Who Underwent Radical Prostatectomy Using Contemporary Protocols at a High-volume Korean Center
      D. H. Lee, H. B. Jung, S. H. Lee, K. H. Rha, Y. D. Choi, S. J. Hong, S. C. Yang, B. H. Chung
      Japanese Journal of Clinical Oncology.2012; 42(11): 1079.     CrossRef
    • Human Papillomavirus Genotypes and Cofactors Causing Cervical Intraepithelial Neoplasia and Cervical Cancer in Korean Women
      Jongseung Kim, Bu Kyung Kim, Chae Hyeong Lee, Sang Soo Seo, Sang-Yoon Park, Ju-Won Roh
      International Journal of Gynecological Cancer.2012; : 1.     CrossRef
    • Do Female Cancer Patients Display Better Survival Rates Compared with Males? Analysis of the Korean National Registry Data, 2005–2009
      Kyu-Won Jung, Sohee Park, Aesun Shin, Chang-Mo Oh, Hyun-Joo Kong, Jae Kwan Jun, Young-Joo Won, Olga Y. Gorlova
      PLoS ONE.2012; 7(12): e52457.     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2009
      Cancer Res Treat. 2012;44(1):11-24.   Published online March 31, 2012
      Close
    • XML DownloadXML Download
    Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2009
    Image Image Image Image Image
    Fig. 1 Annual age-standardized cancer incidence and death rates for all sites by sex during 1983-2009 in Korea. Age standardization was based on the World Health Organization world standard population.
    Fig. 2 Trends in age-standardized cancer incidence for selected cancers by sex during 1999-2009 in Korea. Age standardization was based on the World Health Organization world standard population. (A) Male. (B) Female.
    Fig. 3 Age-specific incidence rates for major cancers during 2009 in Korea. (A) Male. (B) Female.
    Fig. 4 Annual age-standardized cancer mortality for selected cancers by gender during 1983-2009 in Korea. Age standardization was based on the World Health Organization world standard population. (A) Male. (B) Female.
    Fig. 5 Number of prevalent cases by time since diagnosis for major cancer sites on January 1, 2010 in Korea.
    Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2009
    Sites New cases
    Deaths
    10-yr prevalent casesa)
    Both genders Male Female Both genders Male Female Both genders Male Female
    All sites 192,561 99,224 93,337 69,780 43,846 25,934 808,503 371,001 437,502
    Lip, oral cavity, and pharynx 2,511 1,865 646 973 765 208 11,981 8,205 3,776
    Esophagus 2,136 1,975 161 1,406 1,297 109 5,574 5,053 521
    Stomach 29,727 19,953 9,774 10,135 6,680 3,455 145,589 96,919 48,670
    Colon and rectum 24,986 15,068 9,918 7,051 3,929 3,122 115,741 68,566 47,175
    Liver 15,936 11,913 4,023 11,246 8,429 2,817 38,920 29,331 9,589
    Gallbladderb) 4,782 2,379 2,403 3,619 1,775 1,844 10,778 5,512 5,266
    Pancreas 4,427 2,433 1,994 4,058 2,229 1,829 5,085 2,788 2,297
    Larynx 1,148 1,082 66 424 382 42 6,635 6,233 402
    Lung 19,685 14,026 5,659 14,919 10,892 4,027 38,313 25,580 12,733
    Breast 13,460 61 13,399 1,893 15 1,878 86,922 397 86,525
    Cervix uteri 3,733 - 3,733 950 - 950 32,582 - 32,582
    Corpus uteri 1,732 - 1,732 221 - 221 9,982 - 9,982
    Ovary 1,783 - 1,783 854 - 854 10,047 - 10,047
    Prostate 7,351 7,351 - 1,235 1,235 - 29,183 29,183 -
    Testis 200 200 - 23 23 - 1,472 1,472 -
    Kidney 3,435 2,327 1,108 743 501 242 17,015 11,473 5,542
    Bladder 3,203 2,550 653 965 709 256 19,051 15,486 3,565
    Brain and CNS 1,653 893 760 1,065 558 507 6,498 3,422 3,076
    Thyroid 31,977 5,162 26,815 352 111 241 136,388 19,833 116,555
    Hodgkin lymphoma 220 146 74 41 28 13 1,364 869 495
    Non-Hodgkin lymphoma 3,873 2,167 1,706 1,340 778 562 17,656 9,692 7,964
    Multiple myeloma 1,020 568 452 701 374 327 2,731 1,446 1,285
    Leukemia 2,687 1,496 1,191 1,541 855 686 10,554 5,819 4,735
    Other and ill-defined 10,896 5,609 5,287 4,025 2,281 1,744 48,442 23,722 24,720
    Crude incidence rates/100,000 Sites
    Age-standardized incidence rates/100,000a)
    Both genders Male Female Both genders Male Female
    All sites 387.8 398.9 376.7 282.0 325.5 259.3
    Lip, oral cavity, and pharynx 5.1 7.5 2.6 3.7 6.0 1.8
    Esophagus 4.3 7.9 0.6 3.1 6.5 0.4
    Stomach 59.9 80.2 39.4 43.0 64.5 25.5
    Colon and rectum 50.3 60.6 40.0 36.2 49.0 25.9
    Liver 32.1 47.9 16.2 23.2 37.7 10.4
    Gallbladderb) 9.6 9.6 9.7 6.7 8.0 5.7
    Pancreas 8.9 9.8 8.0 6.2 8.0 4.8
    Larynx 2.3 4.3 0.3 1.7 3.6 0.2
    Lung 39.6 56.4 22.8 27.8 46.8 13.9
    Breast 27.1 0.2 54.1 19.4 0.2 38.3
    Cervix uteri 7.5 - 15.1 5.4 - 10.5
    Corpus uteri 3.5 - 7.0 2.6 - 5.0
    Ovary 3.6 - 7.2 2.7 - 5.2
    Prostate 14.8 29.6 - 10.4 24.8 -
    Testis 0.4 0.8 - 0.4 0.8 -
    Kidney 6.9 9.4 4.5 5.1 7.5 3.1
    Bladder 6.5 10.3 2.6 4.5 8.5 1.5
    Brain and CNS 3.3 3.6 3.1 2.9 3.4 2.5
    Thyroid 64.4 20.8 108.2 47.5 15.4 79.6
    Hodgkin lymphoma 0.4 0.6 0.3 0.4 0.5 0.3
    Non-Hodgkin lymphoma 7.8 8.7 6.9 6.0 7.3 5.0
    Multiple myeloma 2.1 2.3 1.8 1.5 1.9 1.2
    Leukemia 5.4 6.0 4.8 5.0 5.9 4.2
    Other and ill-defined 21.9 22.5 21.3 16.5 19.3 14.3
    Rank Cause of death No. of deaths Percent of all deaths Age-standardized
    death rates/100,000a)
    All causes 246,942 100.0 349.5
    1 Cancer 69,780 28.3 97.8
    2 Cerebrovascular disease 25,838 10.5 34.2
    3 Heart disease 22,347 9.0 30.3
    4 Intentional self harm (suicide) 15,413 6.2 23.8
    5 Diabetes mellitus 9,757 4.0 13.1
    6 Transport accidents 7,147 2.9 11.5
    7 Chronic lower respiratory diseases 6,914 2.8 9.0
    8 Disease of liver 6,868 2.8 9.9
    9 Pneumonia 6,324 2.6 8.4
    10 Hypertensive diseases 4,749 1.9 6.3
    Others 71,805 29.1 105.3
    Sites Crude incidence rates/100,000 Sites
    Age-standardized incidence rates/100,000a)
    Both genders Male Female Both genders Male Female
    All sites 140.5 176.3 104.7 97.8 146.7 62.9
    Lip, oral cavity, and pharynx 2.0 3.1 0.8 1.4 2.5 0.5
    Esophagus 2.8 5.2 0.4 2.0 4.3 0.2
    Stomach 20.4 26.9 13.9 14 22.3 8.1
    Colon and rectum 14.2 15.8 12.6 9.7 13.2 7.3
    Liver 22.6 33.9 11.4 16.2 27.1 6.9
    Gallbladderb) 7.3 7.1 7.4 4.9 6.0 4.1
    Pancreas 8.2 9.0 7.4 5.6 7.4 4.2
    Larynx 0.9 1.5 0.2 0.6 1.3 0.1
    Lung 30.0 43.8 16.3 20.5 36.6 9.2
    Breast 3.8 0.1 7.6 2.7 0.1 5.2
    Cervix uteri 1.9 - 3.8 1.3 - 2.4
    Corpus uteri 0.4 - 0.9 0.3 - 0.6
    Ovary 1.7 - 3.4 1.2 - 2.3
    Prostate 2.5 5.0 - 1.6 4.6 -
    Testis 0.0 0.1 - 0.0 0.1 -
    Kidney 1.5 2.0 1.0 1 1.6 0.6
    Bladder 1.9 2.9 1.0 1.3 2.5 0.5
    Brain and CNS 2.1 2.2 2.0 1.7 1.9 1.5
    Thyroid 0.7 0.4 1.0 0.5 0.4 0.5
    Hodgkin lymphoma 0.1 0.1 0.1 0.1 0.1 0.0
    Non-Hodgkin lymphoma 2.7 3.1 2.3 1.9 2.6 1.4
    Multiple myeloma 1.4 1.5 1.3 1.0 1.2 0.8
    Leukemia 3.1 3.4 2.8 2.5 3.0 2.1
    Other and ill-defined 8.1 9.2 7.0 5.8 7.8 4.3
    Sites Year
    1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 APCa)
    All sites 210.5 205.1 216.7 220.1 227.2 234.3 247.0 251.0 261.7 273.5 282.0 3.3b)
    Lip, oral cavity, and pharynx 3.6 4.4 3.6 3.7 3.8 3.8 3.8 3.8 3.9 4.0 3.7 0.1
    Esophagus 4.1 3.7 3.9 3.8 3.6 3.5 3.5 3.4 3.3 3.3 3.1 -2.2b)
    Stomach 43.6 42.3 44.0 43.6 43.2 41.1 44.4 42.8 41.6 42.4 43.0 -0.2
    Colon and rectum 20.4 21.0 22.9 24.7 26.8 28.5 30.8 32.3 33.4 34.4 36.2 6.2b)
    Liver 27.9 26.7 27.3 26.5 25.7 25.5 25.8 24.5 24.3 23.9 23.2 -1.7b)
    Gallbladderc) 6.5 6.4 6.7 6.7 6.7 6.9 7.1 6.6 6.5 6.4 6.7 0.1
    Pancreas 5.6 5.5 5.5 5.8 5.8 6.0 6.3 6.2 6.3 6.4 6.2 1.6b)
    Larynx 2.3 2.2 2.4 2.2 2.1 1.9 2.0 1.8 1.8 1.6 1.7 -3.6b)
    Lung 28.5 27.7 28.3 28.5 27.8 28.8 28.9 28.6 28.3 28.0 27.8 0.0
    Breast 10.7 10.8 12.7 13.9 14.2 14.9 16.2 16.9 18.0 18.8 19.4 6.3b)
    Cervix uteri 8.5 7.9 8.3 7.7 7.4 6.8 6.4 6.3 5.7 5.8 5.4 -4.6b)
    Corpus uteri 1.4 1.3 1.5 1.7 1.9 1.9 2.0 2.1 2.1 2.4 2.6 6.2b)
    Ovary 2.7 2.5 2.5 2.6 2.7 2.7 2.8 2.8 3.0 2.8 2.7 1.2b)
    Prostate 3.1 2.7 3.6 3.9 4.8 6.0 6.3 7.2 8.6 9.7 10.4 14.9b)
    Testis 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4 3.9b)
    Kidney 3.0 2.9 3.3 3.4 3.5 3.7 4.1 4.4 4.8 5.0 5.1 6.3b)
    Bladde 4.6 4.6 4.9 4.7 5.1 5.1 5.1 4.9 5.0 4.8 4.5 0.1
    Brain and CNS 2.9 2.8 2.8 2.6 2.9 2.9 3.0 2.9 3.1 3.0 2.9 0.8b)
    Thyroid 6.3 6.1 7.9 9.5 12.7 17.2 20.6 25.4 32.7 41.2 47.5 24.9b)
    Hodgkin lymphoma 0.2 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.4 0.4 0.4 4.5b)
    Non-Hodgkin lymphoma 4.5 4.2 4.5 4.6 4.9 5.2 5.3 5.5 5.5 5.6 6.0 3.4b)
    Multiple myeloma 1.0 1.0 1.1 1.1 1.1 1.2 1.3 1.3 1.4 1.4 1.5 4.1b)
    Leukemia 4.7 4.3 4.7 4.8 4.7 4.8 4.7 4.9 4.8 5.0 5.0 1.0b)
    Other and ill-defined 14.3 13.5 13.9 13.5 15.1 15.1 16.0 16.0 16.9 16.8 16.5 -
    Sites Year
    1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 APCa)
    All sites 285.0 276.7 288.3 290.0 294.4 298.8 310.6 309.2 315.2 321.2 325.5 1.6b)
    Lip, oral cavity, and pharynx 6.1 7.1 6.0 6.2 6.5 6.1 6.0 6.1 6.3 6.4 6.0 -0.4
    Esophagus 8.8 8.0 8.3 8.2 7.7 7.7 7.6 7.2 6.9 7.0 6.5 -2.6b)
    Stomach 66.2 65.0 67.2 66.6 5.9 62.2 66.8 65.2 62.9 64.2 64.5 -0.4
    Colon and rectum 26.2 27.2 29.6 32.9 35.2 37.8 41.0 43.1 45.0 46.3 49.0 6.8b)
    Liver 46.8 44.7 45.1 43.9 42.3 42.1 42.6 40.2 39.6 39.2 37.7 -1.9b)
    Gallbladderc) 8.1 7.8 8.2 8.1 7.8 8.4 8.7 8.1 7.9 7.6 8.0 -0.2
    Pancreas 7.8 7.6 7.6 7.9 7.7 8.0 8.3 8.0 8.2 8.3 8.0 0.7b)
    Larynx 4.9 4.5 5.1 4.7 4.5 4.1 4.3 3.7 3.8 3.5 3.6 -3.6b)
    Lung 51.4 49.8 51.1 51.0 49.9 50.8 50.8 49.1 48.6 47.4 46.8 -0.8b)
    Breast 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.1 0.3 0.2 -2.0
    Prostate 8.4 7.2 9.5 10.1 12.4 15.0 15.7 17.9 20.8 23.3 24.8 13.4b)
    Testis 0.6 0.5 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.7 0.8 3.8b)
    Kidney 4.5 4.4 4.9 5.0 5.2 5.5 6.0 6.5 7.0 7.4 7.5 5.9b)
    Bladder 9.0 9.0 9.4 9.0 9.7 9.8 9.8 9.6 9.3 9.1 8.5 -0.1
    Brain and CNS 3.2 3.1 3.1 2.9 3.3 3.3 3.3 3.1 3.3 3.3 3.4 0.9b)
    Thyroid 2.1 1.9 2.4 2.7 3.7 4.8 5.9 7.5 10.0 13.2 15.4 24.8b)
    Hodgkin lymphoma 0.4 0.4 0.4 0.3 0.4 0.5 0.4 0.4 0.5 0.5 0.5 3.1b)
    Non-Hodgkin lymphoma 5.8 5.5 5.8 5.8 6.2 6.6 6.4 6.8 7.0 6.7 7.3 2.6b)
    Multiple myeloma 1.2 1.3 1.4 1.4 1.4 1.4 1.6 1.4 1.6 1.6 1.9 3.5b)
    Leukemia 5.5 5.0 5.4 5.8 5.5 5.7 5.5 5.6 5.7 5.7 5.9 0.9b)
    Other and ill-defined 17.9 16.5 16.8 16.5 18.4 18.1 19.1 18.7 20.0 19.5 19.3 -
    Sites Year
    1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 APCa)
    All sites 161.1 157.4 169.0 174.6 183.9 192.9 207.0 215.5 230.6 247.5 259.3 5.3b)
    Lip, oral cavity, and pharynx 1.6 2.4 1.7 1.7 1.7 1.9 1.9 1.8 1.9 1.9 1.8 0.4
    Esophagus 0.6 0.6 0.6 0.5 0.6 0.5 0.4 0.5 0.5 0.5 0.4 -2.9b)
    Stomach 26.7 25.2 26.2 26.3 25.9 24.7 26.8 25.0 24.7 25.0 25.5 -0.5
    Colon and rectum 16.4 16.4 17.9 18.8 20.5 21.4 22.9 23.9 24.4 24.9 25.9 5.1b)
    Liver 12.3 11.8 12.2 11.8 11.5 11.3 11.3 11.1 11.0 10.6 10.4 -1.5b)
    Gallbladderc) 5.3 5.5 5.7 5.8 5.8 5.9 6.0 5.5 5.6 5.5 5.7 0.2
    Pancreas 4.0 4.0 4.0 4.2 4.4 4.5 4.7 4.7 4.7 4.9 4.8 2.3b)
    Larynx 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.2 -8.5b)
    Lung 12.4 12.5 12.3 12.6 12.4 13.0 13.5 14.0 13.9 14.1 13.9 1.5b)
    Breast 20.9 20.9 24.7 27.2 27.8 29.2 31.8 33.1 35.4 37.0 38.3 6.5b)
    Cervix uteri 16.3 15.1 15.8 14.8 14.2 13.1 12.3 12.2 11.0 11.3 10.5 6.4b)
    Corpus uteri 2.8 2.6 3.0 3.3 3.8 3.7 3.9 4.0 4.2 4.7 5.0 -4.4b)
    Ovary 5.0 4.8 4.8 5.0 5.1 5.2 5.4 5.4 5.9 5.5 5.2 1.4b)
    Kidney 1.7 1.8 1.9 2.0 2.1 2.2 2.5 2.7 2.8 3.0 3.1 6.5b)
    Bladder 1.6 1.6 1.7 1.7 1.8 1.7 1.7 1.6 1.7 1.6 1.5 -0.3
    Brain and CNS 2.6 2.5 2.5 2.4 2.5 2.6 2.8 2.6 2.8 2.6 2.5 0.6
    Thyroid 10.4 10.1 13.2 16.2 21.8 29.5 35.2 43.2 55.4 69.2 79.6 25.1b)
    Hodgkin lymphoma 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3 6.7b)
    Non-Hodgkin lymphoma 3.4 3.2 3.4 3.5 3.9 4.1 4.4 4.3 4.3 4.7 5.0 4.4b)
    Multiple myeloma 0.8 0.8 0.9 0.8 1.0 1.0 1.2 1.1 1.2 1.2 1.2 5.0b)
    Leukemia 3.9 3.8 4.1 4.0 4.1 4.1 4.0 4.4 4.1 4.3 4.2 1.0b)
    Other and ill-defined 11.8 11.5 11.8 11.5 12.6 12.9 13.7 13.9 14.5 14.6 14.3 -
    Rank Age group (yr)
    0-14 15-34 35-64 ≥65
    Male
    1 Leukemia Thyroid Stomach Lung
    (5.0) (9.4) (95.8) (451.5)
    2 Brain and CNS Stomach Colon and rectum Stomach
    (2.4) (3.1) (71.1) (443.9)
    3 Non-Hodgkin lymphoma Leukemia Liver Colon and rectum
    (1.6) (3.0) (68.1) (340.7)
    4 Kidney Colon and rectum Lung Prostate
    (0.5) (2.7) (41.8) (268.2)
    5 Testis Non-Hodgkin lymphoma Thyroid Liver
    (0.4) (2.6) (35.9) (209.2)
    Female
    1 Leukemia Thyroid Thyroid Colon and rectum
    (3.5) (52.1) (192.5) (171.0)
    2 Brain and CNS Breast Breast Stomach
    (1.7) (10.0) (102.8) (160.5)
    3 Non-Hodgkin lymphoma Cervix uteri Stomach Lung
    (1.1) (5.3) (42.2) (120.5)
    4 Ovary Stomach Colon and rectum Thyroid
    (0.8) (4.2) (41.6) (82.1)
    5 Kidney, thyroid Colon and rectum Cervix uteri Liver
    (0.3) , (0.3) (2.6) (22.0) (76.9)
    Sites Both genders
    Male
    Female
    1993-1995 1996-2000 2001-2005 2005-2009 Changea) 1993-1995 1996-2000 2001-2005 2005-2009 Changea) 1993-1995 1996-2000 2001-2005 2005-2009 Changea)
    All sites 41.2 44.0 53.7 62.0 20.8 31.7 35.3 45.2 53.2 21.5 53.4 55.3 63.9 71.4 18.0
    Lip, oral cavity, and pharynx 41.1 46.7 54.1 58.9 17.8 35.8 41.1 49.2 54.3 18.5 58.1 63.8 67.7 70.9 12.8
    Esophagus 12.7 15.2 21.1 27.5 14.8 11.8 14.3 20.4 26.7 14.9 23.7 24.2 29.3 36.6 12.9
    Stomach 42.8 46.6 57.7 65.3 22.5 43.0 46.9 58.4 65.9 22.9 42.6 46.0 56.3 64.0 21.4
    Colon and rectum 54.8 58.0 66.6 71.3 16.5 55.3 59.0 68.5 73.2 17.9 54.2 56.8 64.1 68.7 14.5
    Liver 10.7 13.2 20.1 25.1 14.4 9.9 12.9 20.0 25.1 15.2 13.6 14.2 20.3 25.1 11.5
    Gallbladderb) 17.3 19.7 22.8 26.1 8.8 16.6 20.3 23.3 27.0 10.4 18.0 19.1 22.3 25.2 7.2
    Pancreas 9.4 7.6 8.0 8.0 1.4 8.8 7.3 8.0 7.9 0.9 10.1 8.1 8.0 8.2 -1.9
    Larynx 59.7 62.3 66.2 71.3 11.6 60.2 62.8 66.8 71.6 11.4 55.4 57.8 58.2 65.9 10.5
    Lung 11.3 12.7 16.1 19.0 7.7 10.4 11.6 14.9 17.1 6.7 14.2 16.2 19.6 23.9 9.7
    Breast 77.9 83.2 88.4 90.6 12.7 75.1 85.6 86.9 92.0 16.9 78.0 83.2 88.5 90.6 12.6
    Cervix uteri 77.5 80.0 81.2 80.3 2.8 - - - - - 77.5 80.0 81.2 80.3 2.8
    Corpus uteri 81.5 81.8 84.7 84.9 3.4 - - - - - 81.5 81.8 84.7 84.9 3.4
    Ovary 58.7 58.9 61.3 60.2 1.5 - - - - - 58.7 58.9 61.3 60.2 1.5
    Prostate 55.9 67.2 79.9 87.6 31.7 55.9 67.2 79.9 87.6 31.7 - - - - -
    Testis 85.4 90.4 90.6 92.3 6.9 85.4 90.4 90.6 92.3 6.9 - - - - -
    Kidney 62.0 66.1 73.3 77.1 15.1 60.8 64.4 72.7 77.2 16.4 64.5 69.7 74.4 76.8 12.3
    Bladder 69.1 73.1 75.4 76.0 6.9 70.0 74.8 77.2 77.6 7.6 65.5 66.3 68.4 69.3 3.8
    Brain and CNS 38.5 39.0 40.4 43.3 4.8 37.2 37.5 39.7 42.1 4.9 40.2 40.7 41.2 44.6 4.4
    Thyroid 94.2 94.9 98.3 99.7 5.5 87.2 89.5 95.7 99.3 12.1 95.4 95.9 98.7 99.8 4.4
    Hodgkin lymphoma 68.0 71.2 76.7 81.9 13.9 67.6 68.1 74.7 81.1 13.5 68.6 77.4 80.6 83.3 14.7
    Non-Hodgkin lymphoma 46.6 50.8 59.8 64.2 17.6 45.3 48.9 58.0 62.3 17.0 48.7 53.5 62.3 66.6 17.9
    Multiple myeloma 22.1 19.8 29.3 34.3 12.2 21.1 17.8 29.7 34.7 13.6 23.3 22.1 28.8 33.9 10.6
    Leukemia 26.5 33.3 41.6 46.0 19.5 26.2 32.3 41.5 45.1 18.9 26.8 34.6 41.8 47.2 20.4
    Other and ill-defined 42.1 45.9 55.4 62.6 20.5 37.4 42.4 51.8 58.9 21.5 47.4 50.0 59.4 66.4 19.0
    Sites Crude 10-yr prevalent rates/100,000
    Age-standardized 10-yr prevalent rates/100,000a)
    Both genders Male Female Both genders Male Female
    All sites 1,628.2 1,491.4 1,765.5 1,193.2 1,218.2 1,237.3
    Lip, oral cavity, and pharynx 24.1 33.0 15.2 17.9 26.4 10.7
    Esophagus 11.2 20.3 2.1 8.1 16.8 1.3
    Stomach 293.2 389.6 196.4 211.1 312.9 128.5
    Colon and rectum 233.1 275.6 190.4 167.4 223.8 123.4
    Liver 78.4 117.9 38.7 58.2 93.8 26.7
    Gallbladderb) 21.7 22.2 21.3 15.4 18.2 13.3
    Pancreas 10.2 11.2 9.3 7.4 9.1 6.0
    Larynx 13.4 25.1 1.6 9.7 20.7 1.0
    Lung 77.2 102.8 51.4 55.5 84.5 33.3
    Breast 175.0 1.6 349.2 125.9 1.3 247.0
    Cervix uteri 65.6 - 131.5 47.0 - 91.0
    Corpus uteri 20.1 - 40.3 14.9 - 29.1
    Ovary 20.2 - 40.5 15.5 - 30.5
    Prostate 58.8 117.3 - 40.2 99.2 -
    Testis 3.0 5.9 - 2.8 5.4 -
    Kidney 34.3 46.1 22.4 25.7 36.8 16.1
    Bladder 38.4 62.3 14.4 26.8 51.5 8.6
    Brain and CNS 13.1 13.8 12.4 11.8 12.7 10.9
    Thyroid 274.7 79.7 470.4 201.7 59.6 342.6
    Hodgkin lymphoma 2.7 3.5 2.0 2.4 3.0 1.8
    Non-Hodgkin lymphoma 35.6 39.0 32.1 27.8 32.5 23.8
    Multiple myeloma 5.5 5.8 5.2 4.0 4.7 3.5
    Leukemia 21.3 23.4 19.1 21.0 23.4 18.7
    Other and ill-defined 97.6 95.4 99.8 75.0 82.1 69.4
    Table 1 Number of cancer incidence cases, deaths, and prevalent cases by gender during 2009 in Korea

    CNS, central nervous system. a)10-yr prevalent cases: limited-duration prevalent cases on January 1, 2010. These are patients that were diagnosed between January 1, 2000 and December 31, 2009 and were alive on January 1, 2010. Multiple primary cancer cases were counted multiple times, b)Includes gallbladder and other/unspecified parts of the biliary tract.

    Table 2 Crude and age-standardized cancer incidence rates by gender during 2009 in Korea

    CNS, central nervous system. a)Age adjusted to the World Health Organization world standard population, b)Includes gallbladder and other/unspecified parts of the biliary tract.

    Table 3 Ten leading causes of death during 2009 in Korea

    Source: Mortality Data, 2009, Korea National Statistical Office. a)Age adjusted to the World Health Organization world standard population.

    Table 4 Crude and age-standardized cancer mortality rates by gender during 2009 in Korea

    CNS, central nervous system. a)Age adjusted to the World Health Organization world standard population, b)Includes gallbladder and other/unspecified parts of the biliary tract.

    Table 5 Trends in cancer incidence rates in both sexes during 1999-2009 in Korea

    APC, annual percent change; CNS, central nervous system. a)APC using age-standardized incidence based on the World Health Organization world standard population, b)APC was significantly different from zero (p < 0.05), c)Includes gallbladder and other/unspecified parts of the biliary tract.

    Table 6 Trends in cancer incidence rates in males during 1999-2009 in Korea

    APC, annual percent change; CNS, central nervous system. a)APC using age-standardized incidence based on the World Health Organization world standard population, b)APC was significantly different from zero (p < 0.05), c)Includes gallbladder and other/unspecified parts of the biliary tract.

    Table 7 Trends in cancer incidence rates in females during 1999-2009 in Korea

    APC, annual percent change; CNS, central nervous system. a)APC using age-standardized incidence based on the World Health Organization world standard population, b)APC was significantly different from zero (p < 0.05), c)Includes gallbladder and other/unspecified parts of the biliary tract.

    Table 8 Five major sites of cancer incidence by age group and gender during 2009 in Korea

    CNS, central nervous system.

    Table 9 Trends in the 5-yr relative survival rates (%) by year of diagnosis during 1993-2009 in Korea

    CNS, central nervous system. a)Change in the 5-yr relative survival between 1993-1995 and 2005-2009 as a percentage, b)Includes gallbladder and other/unspecified parts of the biliary tract.

    Table 10 Crude and age-standardized rates of 10-yr cancer prevalence on January 1, 2010 by gender during 2009 in Korea

    CNS, central nervous system. a)Age adjusted to the World Health Organization world standard population, b)Includes gallbladder and other/unspecified parts of the biliary tract.


    Cancer Res Treat : Cancer Research and Treatment
    Close layer
    TOP